Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL1825):

Molecule: INFLIXIMAB
ChEMBL ID: CHEMBL1201581
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 1998

Molecule: CERTOLIZUMAB PEGOL
ChEMBL ID: CHEMBL1201831
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2008

Molecule: ADALIMUMAB
ChEMBL ID: CHEMBL1201580
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2002

Molecule: ETANERCEPT
ChEMBL ID: CHEMBL1201572
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Protein
First Approval: 1998

Molecule: GOLIMUMAB
ChEMBL ID: CHEMBL1201833
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2009

Molecule: LENERCEPT
ChEMBL ID: CHEMBL2108208
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Protein

Molecule: NERELIMOMAB
ChEMBL ID: CHEMBL2108566
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody

Molecule: AFELIMOMAB
ChEMBL ID: CHEMBL2108887
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: ONERCEPT
ChEMBL ID: CHEMBL2107911
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Protein

Molecule: OZORALIZUMAB
ChEMBL ID: CHEMBL1743054
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: PEGSUNERCEPT
ChEMBL ID: CHEMBL1743057
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Protein

Molecule: PLACULUMAB
ChEMBL ID: CHEMBL2108739
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: AZ9773
ChEMBL ID: CHEMBL2109587
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: REMTOLUMAB
ChEMBL ID: CHEMBL4297863
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: ABBV-3373
ChEMBL ID: CHEMBL4297572
Mechanism of Action: BINDING AGENT
Max Phase: 2.0
Molecule Type: Unknown
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2096670):

Molecule: PERAMPANEL
ChEMBL ID: CHEMBL1214124
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2012

Molecule: TOPIRAMATE
ChEMBL ID: CHEMBL220492
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1996

Molecule: IRAMPANEL
ChEMBL ID: CHEMBL29741
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: CX1739
ChEMBL ID: CHEMBL3707399
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: PESAMPATOR
ChEMBL ID: CHEMBL5095022
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: SELURAMPANEL
ChEMBL ID: CHEMBL3545042
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: TEZAMPANEL
ChEMBL ID: CHEMBL3989703
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: DASOLAMPANEL
ChEMBL ID: CHEMBL2103869
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: BECAMPANEL
ChEMBL ID: CHEMBL3989682
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: FARAMPATOR
ChEMBL ID: CHEMBL1276138
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: MIBAMPATOR
ChEMBL ID: CHEMBL1277001
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: MK-8777
ChEMBL ID: CHEMBL3707401
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: ZONAMPANEL
ChEMBL ID: CHEMBL119625
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: OSAVAMPATOR
ChEMBL ID: CHEMBL4594403
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL1884):

Molecule: LEVAMISOLE HYDROCHLORIDE
ChEMBL ID: CHEMBL1770
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1990
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL223):

Molecule: NAFTOPIDIL
ChEMBL ID: CHEMBL142635
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1999
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL229):

Molecule: PHENYLPROPANOLAMINE POLISTIREX
ChEMBL ID: CHEMBL1201535
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1984

Molecule: SILODOSIN
ChEMBL ID: CHEMBL24778
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2008

Molecule: DAPIPRAZOLE HYDROCHLORIDE
ChEMBL ID: CHEMBL1201044
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1990

Molecule: PHENYLPROPANOLAMINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1200695
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1958

Molecule: TEDATIOXETINE
ChEMBL ID: CHEMBL2104986
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: DABUZALGRON
ChEMBL ID: CHEMBL257978
Mechanism of Action: PARTIAL AGONIST
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL1916):

Molecule: ORM-12741
ChEMBL ID: CHEMBL4297312
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL1947):

Molecule: RESMETIROM
ChEMBL ID: CHEMBL3261331
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: MB07811
ChEMBL ID: CHEMBL471897
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: EPROTIROME
ChEMBL ID: CHEMBL2035874
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2492):

Molecule: AVL-3288
ChEMBL ID: CHEMBL429317
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: PHA-543613
ChEMBL ID: CHEMBL214268
Mechanism of Action: AGONIST
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: ABT-107
ChEMBL ID: CHEMBL2151570
Mechanism of Action: AGONIST
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: APN1125
ChEMBL ID: CHEMBL3545013
Mechanism of Action: PARTIAL AGONIST
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: AZD0328
ChEMBL ID: CHEMBL2151437
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: BRADANICLINE
ChEMBL ID: CHEMBL1258006
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: ABT-126
ChEMBL ID: CHEMBL3545231
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: AQW051
ChEMBL ID: CHEMBL3545232
Mechanism of Action: PARTIAL AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: JNJ-39393406
ChEMBL ID: CHEMBL3545291
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: SSR180711
ChEMBL ID: CHEMBL559478
Mechanism of Action: PARTIAL AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: FACINICLINE HYDROCHLORIDE
ChEMBL ID: CHEMBL5095032
Mechanism of Action: PARTIAL AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: TC-6987
ChEMBL ID: CHEMBL5314402
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: ND0801
ChEMBL ID: CHEMBL3707316
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: ASM-024
ChEMBL ID: CHEMBL3707249
Mechanism of Action: MODULATOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: ENCENICLINE
ChEMBL ID: CHEMBL2151572
Mechanism of Action: PARTIAL AGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: GTS-21
ChEMBL ID: CHEMBL134713
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: BNC-210
ChEMBL ID: CHEMBL4650452
Mechanism of Action: NEGATIVE ALLOSTERIC MODULATOR
Max Phase: 2.0
Molecule Type: Unknown
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2009):

Molecule: TALAMPANEL
ChEMBL ID: CHEMBL61872
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL4016):

Molecule: TALAMPANEL
ChEMBL ID: CHEMBL61872
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL1075259):

Molecule: SUVRATOXUMAB
ChEMBL ID: CHEMBL3989997
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody

Molecule: TOSATOXUMAB
ChEMBL ID: CHEMBL4594526
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2094251):

Molecule: TRIMIPRAMINE MALEATE
ChEMBL ID: CHEMBL1200948
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1979

Molecule: PHENYLEPHRINE BITARTRATE
ChEMBL ID: CHEMBL2062264
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1973

Molecule: CARVEDILOL
ChEMBL ID: CHEMBL723
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1995

Molecule: ALFUZOSIN HYDROCHLORIDE
ChEMBL ID: CHEMBL1723
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2003

Molecule: DOXAZOSIN MESYLATE
ChEMBL ID: CHEMBL1200561
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1990

Molecule: METHOXAMINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1201103
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1982

Molecule: METARAMINOL BITARTRATE
ChEMBL ID: CHEMBL2062262
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1954

Molecule: CARVEDILOL PHOSPHATE
ChEMBL ID: CHEMBL1201167
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2006

Molecule: MIDODRINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1200461
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1996

Molecule: PHENYLEPHRINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1200339
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1952

Molecule: PRAZOSIN HYDROCHLORIDE
ChEMBL ID: CHEMBL1558
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1976

Molecule: TAMSULOSIN HYDROCHLORIDE
ChEMBL ID: CHEMBL1200914
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1997

Molecule: TERAZOSIN HYDROCHLORIDE
ChEMBL ID: CHEMBL3989562
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1987

Molecule: ISOXSUPRINE HYDROCHLORIDE
ChEMBL ID: CHEMBL559180
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: SERTINDOLE
ChEMBL ID: CHEMBL12713
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1996

Molecule: BUNAZOSIN
ChEMBL ID: CHEMBL188185
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: BUCINDOLOL HYDROCHLORIDE
ChEMBL ID: CHEMBL2107546
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2095158):

Molecule: BRIMONIDINE TARTRATE
ChEMBL ID: CHEMBL2062257
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1996

Molecule: DEXMEDETOMIDINE HYDROCHLORIDE
ChEMBL ID: CHEMBL2106195
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1999

Molecule: TIZANIDINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1200329
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1996

Molecule: MIRTAZAPINE
ChEMBL ID: CHEMBL654
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1996

Molecule: CLONIDINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1705
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1974

Molecule: METHYLDOPATE HYDROCHLORIDE
ChEMBL ID: CHEMBL1200432
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1962

Molecule: GUANFACINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1200494
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1986

Molecule: CLONIDINE
ChEMBL ID: CHEMBL134
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1974

Molecule: APRACLONIDINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1200379
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1987

Molecule: METHYLDOPA
ChEMBL ID: CHEMBL459
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1962

Molecule: GUANABENZ ACETATE
ChEMBL ID: CHEMBL1200560
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1982

Molecule: LEVONORDEFRIN
ChEMBL ID: CHEMBL677
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1960

Molecule: FADOLMIDINE HYDROCHLORIDE
ChEMBL ID: CHEMBL2106710
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: ESMIRTAZAPINE MALEATE
ChEMBL ID: CHEMBL2107339
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: CELIPROLOL
ChEMBL ID: CHEMBL27810
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: LOFEXIDINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1788132
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2018

Molecule: FIPAMEZOLE
ChEMBL ID: CHEMBL1255582
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: IDAZOXAN
ChEMBL ID: CHEMBL10316
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2095203):

Molecule: ALSEROXYLON
ChEMBL ID: CHEMBL1201454
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Unknown
First Approval: 1982

Molecule: ERGOLOID MESYLATES
ChEMBL ID: CHEMBL2311030
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Unknown
First Approval: 1953

Molecule: ERGOTAMINE TARTRATE
ChEMBL ID: CHEMBL2448612
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1948

Molecule: NAPHAZOLINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1706
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1971

Molecule: TETRAHYDROZOLINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1200413
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1979

Molecule: PHENTOLAMINE MESYLATE
ChEMBL ID: CHEMBL1200873
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1952

Molecule: OXYMETAZOLINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1200791
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1986

Molecule: RAUWOLFIA SERPENTINA
ChEMBL ID: CHEMBL3559672
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Unknown
First Approval: 1954

Molecule: PHENOXYBENZAMINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1200787
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1953

Molecule: TOLAZOLINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1689
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1985

Molecule: MOXISYLYTE
ChEMBL ID: CHEMBL159226
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: AVIPTADIL
ChEMBL ID: CHEMBL1981592
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Protein

Molecule: XYLOMETAZOLINE
ChEMBL ID: CHEMBL312448
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2109238):

Molecule: NERAMEXANE MESYLATE
ChEMBL ID: CHEMBL2106798
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2111462):

Molecule: DEXTROTHYROXINE SODIUM
ChEMBL ID: CHEMBL3545058
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1967

Molecule: LIOTHYRONINE SODIUM
ChEMBL ID: CHEMBL1201119
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1956

Molecule: DEXTROTHYROXINE
ChEMBL ID: CHEMBL559
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1967

Molecule: LIOTHYRONINE
ChEMBL ID: CHEMBL1544
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1956

Molecule: LEVOTHYROXINE SODIUM
ChEMBL ID: CHEMBL2103741
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2000
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2331074):

Molecule: LABETALOL HYDROCHLORIDE
ChEMBL ID: CHEMBL1200323
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1984

Molecule: DIPIVEFRIN HYDROCHLORIDE
ChEMBL ID: CHEMBL1200833
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1980

Molecule: EPINEPHRINE BITARTRATE
ChEMBL ID: CHEMBL1256958
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1965

Molecule: EPINEPHRINE
ChEMBL ID: CHEMBL679
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1976

Molecule: MEPHENTERMINE SULFATE
ChEMBL ID: CHEMBL3184799
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1951

Molecule: NOREPINEPHRINE BITARTRATE
ChEMBL ID: CHEMBL1434513
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1950

Molecule: HYDROXYAMPHETAMINE HYDROBROMIDE
ChEMBL ID: CHEMBL1200705
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1969

Molecule: DROXIDOPA
ChEMBL ID: CHEMBL2103827
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2014

Molecule: EPHEDRINE SULFATE
ChEMBL ID: CHEMBL1523964
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2016

Molecule: EPHEDRINE HYDROCHLORIDE
ChEMBL ID: CHEMBL2146102
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2021
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2364188):

Molecule: COLLAGENASE CLOSTRIDIUM HISTOLYTICUM
ChEMBL ID: CHEMBL2108709
Mechanism of Action: HYDROLYTIC ENZYME
Max Phase: 4.0
Molecule Type: Enzyme
First Approval: 2010

Molecule: OCRIPLASMIN
ChEMBL ID: CHEMBL2095222
Mechanism of Action: HYDROLYTIC ENZYME
Max Phase: 4.0
Molecule Type: Protein
First Approval: 2010
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3712864):

Molecule: YTTRIUM Y 90 TACATUZUMAB TETRAXETAN
ChEMBL ID: CHEMBL2108669
Mechanism of Action: BINDING AGENT
Max Phase: 2.0
Molecule Type: Antibody drug conjugate
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3856161):

Molecule: RONTALIZUMAB
ChEMBL ID: CHEMBL1743066
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: SIFALIMUMAB
ChEMBL ID: CHEMBL1743069
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL4630891):

Molecule: ANFIBATIDE
ChEMBL ID: CHEMBL4297694
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Protein
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL206):

Molecule: POLYESTRADIOL PHOSPHATE
ChEMBL ID: CHEMBL1201477
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1957

Molecule: TAMOXIFEN CITRATE
ChEMBL ID: CHEMBL786
Mechanism of Action: MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1977

Molecule: ESTRONE
ChEMBL ID: CHEMBL1405
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1979

Molecule: ESTRADIOL
ChEMBL ID: CHEMBL135
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1975

Molecule: ESTRADIOL ACETATE
ChEMBL ID: CHEMBL1200430
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2003

Molecule: ESTRADIOL VALERATE
ChEMBL ID: CHEMBL1511
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2010

Molecule: CLOMIPHENE CITRATE
ChEMBL ID: CHEMBL3185958
Mechanism of Action: MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1967

Molecule: ETHINYL ESTRADIOL
ChEMBL ID: CHEMBL691
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2001

Molecule: DIENESTROL
ChEMBL ID: CHEMBL1018
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1947

Molecule: ESTRADIOL CYPIONATE
ChEMBL ID: CHEMBL1200973
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1979

Molecule: ESTROPIPATE
ChEMBL ID: CHEMBL1200980
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1977

Molecule: MESTRANOL
ChEMBL ID: CHEMBL1201151
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1961

Molecule: DIETHYLSTILBESTROL
ChEMBL ID: CHEMBL411
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1973

Molecule: SR16234
ChEMBL ID: CHEMBL3545210
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: ELACESTRANT
ChEMBL ID: CHEMBL4297509
Mechanism of Action: DEGRADER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2023

Molecule: BRILANESTRANT
ChEMBL ID: CHEMBL3581693
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: GTX-758
ChEMBL ID: CHEMBL3545017
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: ENCLOMIPHENE
ChEMBL ID: CHEMBL954
Mechanism of Action: MODULATOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: CAMIZESTRANT
ChEMBL ID: CHEMBL4650365
Mechanism of Action: DEGRADER
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: AMCENESTRANT
ChEMBL ID: CHEMBL4475463
Mechanism of Action: DEGRADER
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: GIREDESTRANT
ChEMBL ID: CHEMBL4650316
Mechanism of Action: DEGRADER
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: ELACESTRANT HYDROCHLORIDE
ChEMBL ID: CHEMBL4594273
Mechanism of Action: DEGRADER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2023
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2055):

Molecule: NRX195183
ChEMBL ID: CHEMBL107430
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: TAMIBAROTENE
ChEMBL ID: CHEMBL25202
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2005
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL1806):

Molecule: ETOPOSIDE PHOSPHATE
ChEMBL ID: CHEMBL1200645
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1996

Molecule: DAUNORUBICIN CITRATE
ChEMBL ID: CHEMBL1200475
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1996

Molecule: DAUNORUBICIN HYDROCHLORIDE
ChEMBL ID: CHEMBL1563
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1979

Molecule: DOXORUBICIN HYDROCHLORIDE
ChEMBL ID: CHEMBL359744
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1974

Molecule: MITOXANTRONE HYDROCHLORIDE
ChEMBL ID: CHEMBL1417019
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1987

Molecule: VALRUBICIN
ChEMBL ID: CHEMBL1096885
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1998

Molecule: IDARUBICIN HYDROCHLORIDE
ChEMBL ID: CHEMBL1200976
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1990

Molecule: AMRUBICIN HYDROCHLORIDE
ChEMBL ID: CHEMBL481958
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: ALDOXORUBICIN
ChEMBL ID: CHEMBL2107818
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: AMRUBICIN
ChEMBL ID: CHEMBL1186894
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: GANCOTAMAB
ChEMBL ID: CHEMBL3833344
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: DAUNORUBICIN
ChEMBL ID: CHEMBL178
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1979
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL1962):

Molecule: INDIPLON
ChEMBL ID: CHEMBL262075
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL1856):

Molecule: FINASTERIDE
ChEMBL ID: CHEMBL710
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1992
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL1987):

Molecule: TAFLUPROST
ChEMBL ID: CHEMBL1963683
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2012

Molecule: LATANOPROST
ChEMBL ID: CHEMBL1051
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1996

Molecule: TRAVOPROST
ChEMBL ID: CHEMBL1200799
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2001

Molecule: DINOPROST TROMETHAMINE
ChEMBL ID: CHEMBL1200896
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1982

Molecule: BIMATOPROST
ChEMBL ID: CHEMBL1200963
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2001

Molecule: CARBOPROST TROMETHAMINE
ChEMBL ID: CHEMBL1237105
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1979

Molecule: LATANOPROSTENE BUNOD
ChEMBL ID: CHEMBL2364612
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2017

Molecule: AL-12182
ChEMBL ID: CHEMBL184999
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: SEPETAPROST
ChEMBL ID: CHEMBL4297633
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL239):

Molecule: CHOLINE FENOFIBRATE
ChEMBL ID: CHEMBL1201745
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2008

Molecule: GEMFIBROZIL
ChEMBL ID: CHEMBL457
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1981

Molecule: FENOFIBRATE
ChEMBL ID: CHEMBL672
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1993

Molecule: CLOFIBRATE
ChEMBL ID: CHEMBL565
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1967

Molecule: FENOFIBRIC ACID
ChEMBL ID: CHEMBL981
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2009

Molecule: ZYH7
ChEMBL ID: CHEMBL3545093
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: CP-778875
ChEMBL ID: CHEMBL5314385
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: LY-518674
ChEMBL ID: CHEMBL424133
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: DRF-10945
ChEMBL ID: CHEMBL3545394
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: GW590735
ChEMBL ID: CHEMBL219586
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: AVE8134
ChEMBL ID: CHEMBL3545334
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: NAVEGLITAZAR
ChEMBL ID: CHEMBL181954
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: K-877
ChEMBL ID: CHEMBL3545412
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: IMIGLITAZAR
ChEMBL ID: CHEMBL592054
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: ALEGLITAZAR
ChEMBL ID: CHEMBL519504
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: MURAGLITAZAR
ChEMBL ID: CHEMBL186179
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: TESAGLITAZAR
ChEMBL ID: CHEMBL282686
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: CIPROFIBRATE
ChEMBL ID: CHEMBL557555
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1985

Molecule: PEMAFIBRATE
ChEMBL ID: CHEMBL247951
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2017

Molecule: SAROGLITAZAR
ChEMBL ID: CHEMBL4297530
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: ELAFIBRANOR
ChEMBL ID: CHEMBL3707395
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: MK-0767
ChEMBL ID: CHEMBL4297404
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL242):

Molecule: ESTRAMUSTINE PHOSPHATE SODIUM
ChEMBL ID: CHEMBL1200721
Mechanism of Action: MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1981

Molecule: CHLOROTRIANISENE
ChEMBL ID: CHEMBL1200761
Mechanism of Action: MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1982

Molecule: RALOXIFENE HYDROCHLORIDE
ChEMBL ID: CHEMBL1116
Mechanism of Action: MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1997

Molecule: PRINABEREL
ChEMBL ID: CHEMBL450940
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: ERTEBEREL
ChEMBL ID: CHEMBL278703
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: AUS-131
ChEMBL ID: CHEMBL198877
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: CR 1447
ChEMBL ID: CHEMBL3545092
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: MF101
ChEMBL ID: CHEMBL3545411
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Unknown
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL1778):

Molecule: INOLIMOMAB
ChEMBL ID: CHEMBL2108370
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Antibody

Molecule: LMB-2
ChEMBL ID: CHEMBL2109367
Mechanism of Action: BINDING AGENT
Max Phase: 2.0
Molecule Type: Antibody drug conjugate

Molecule: ANTI-TAC 90 Y-HAT
ChEMBL ID: CHEMBL2109366
Mechanism of Action: BINDING AGENT
Max Phase: 1.0
Molecule Type: Antibody

Molecule: CAMIDANLUMAB TESIRINE
ChEMBL ID: CHEMBL4297871
Mechanism of Action: BINDING AGENT
Max Phase: 2.0
Molecule Type: Antibody drug conjugate
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL1803):

Molecule: ODULIMOMAB
ChEMBL ID: CHEMBL2109177
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2059):

Molecule: PATECLIZUMAB
ChEMBL ID: CHEMBL1743056
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL1913):

Molecule: DASATINIB
ChEMBL ID: CHEMBL1421
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2006

Molecule: SORAFENIB TOSYLATE
ChEMBL ID: CHEMBL1200485
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2005

Molecule: IMATINIB MESYLATE
ChEMBL ID: CHEMBL1642
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2001

Molecule: CM-082
ChEMBL ID: CHEMBL3545427
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: PD-0166285
ChEMBL ID: CHEMBL3545196
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: RG-1530
ChEMBL ID: CHEMBL1980391
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: PUQUITINIB MESYLATE DIHYDRATE
ChEMBL ID: CHEMBL4596972
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: CEP-2563 DIHYDROCHLORIDE
ChEMBL ID: CHEMBL5314390
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: CATEQUENTINIB
ChEMBL ID: CHEMBL4303201
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: TELATINIB
ChEMBL ID: CHEMBL2079588
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: JI-101
ChEMBL ID: CHEMBL3545155
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: TANDUTINIB
ChEMBL ID: CHEMBL124660
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: TG100-801
ChEMBL ID: CHEMBL403989
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: CDP-860
ChEMBL ID: CHEMBL2109544
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: RINUCUMAB
ChEMBL ID: CHEMBL3545316
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: TIVOZANIB HYDROCHLORIDE
ChEMBL ID: CHEMBL2105756
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2017

Molecule: SUNITINIB
ChEMBL ID: CHEMBL535
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2006
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL1887):

Molecule: ANIFROLUMAB
ChEMBL ID: CHEMBL2364653
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2021
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2050):

Molecule: OPRELVEKIN
ChEMBL ID: CHEMBL1201573
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 1997
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL1936):

Molecule: DASATINIB
ChEMBL ID: CHEMBL1421
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2006

Molecule: PAZOPANIB HYDROCHLORIDE
ChEMBL ID: CHEMBL1201733
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2009

Molecule: REGORAFENIB
ChEMBL ID: CHEMBL1946170
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2012

Molecule: SORAFENIB TOSYLATE
ChEMBL ID: CHEMBL1200485
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2005

Molecule: SUNITINIB MALATE
ChEMBL ID: CHEMBL1567
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2006

Molecule: IMATINIB MESYLATE
ChEMBL ID: CHEMBL1642
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2001

Molecule: SU-014813
ChEMBL ID: CHEMBL1721885
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: CM-082
ChEMBL ID: CHEMBL3545427
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: OSI-930
ChEMBL ID: CHEMBL1614710
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: CATEQUENTINIB
ChEMBL ID: CHEMBL4303201
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: TELATINIB
ChEMBL ID: CHEMBL2079588
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: ENMD-2076
ChEMBL ID: CHEMBL482968
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: FORETINIB
ChEMBL ID: CHEMBL1230609
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: TANDUTINIB
ChEMBL ID: CHEMBL124660
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: AMUVATINIB
ChEMBL ID: CHEMBL2103851
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: PEXIDARTINIB
ChEMBL ID: CHEMBL3813873
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2019

Molecule: FAMITINIB
ChEMBL ID: CHEMBL1278146
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: XL-820
ChEMBL ID: CHEMBL3545402
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: XL-999
ChEMBL ID: CHEMBL5314391
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: MASITINIB
ChEMBL ID: CHEMBL1908391
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2008

Molecule: QUIZARTINIB
ChEMBL ID: CHEMBL576982
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2023

Molecule: CEDIRANIB
ChEMBL ID: CHEMBL491473
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: MIDOSTAURIN
ChEMBL ID: CHEMBL608533
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2017

Molecule: VATALANIB
ChEMBL ID: CHEMBL101253
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: SEMAXANIB
ChEMBL ID: CHEMBL276711
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: DOVITINIB
ChEMBL ID: CHEMBL522892
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: MOTESANIB
ChEMBL ID: CHEMBL572881
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: AMG-191
ChEMBL ID: CHEMBL2109325
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Antibody

Molecule: PEXIDARTINIB HYDROCHLORIDE
ChEMBL ID: CHEMBL3989973
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2019

Molecule: AVAPRITINIB
ChEMBL ID: CHEMBL4204794
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2020

Molecule: RIPRETINIB
ChEMBL ID: CHEMBL4216467
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2020

Molecule: TIVOZANIB HYDROCHLORIDE
ChEMBL ID: CHEMBL2105756
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2017

Molecule: SERALUTINIB
ChEMBL ID: CHEMBL4650333
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: SUNITINIB
ChEMBL ID: CHEMBL535
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2006
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2061):

Molecule: SDX-101
ChEMBL ID: CHEMBL1716091
Mechanism of Action: MODULATOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: DANTHRON
ChEMBL ID: CHEMBL53418
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3629):

Molecule: SILMITASERTIB
ChEMBL ID: CHEMBL1230165
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2121):

Molecule: FARLETUZUMAB
ChEMBL ID: CHEMBL1743016
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody

Molecule: VINTAFOLIDE
ChEMBL ID: CHEMBL3039521
Mechanism of Action: BINDING AGENT
Max Phase: 3.0
Molecule Type: Unknown

Molecule: MIRVETUXIMAB SORAVTANSINE
ChEMBL ID: CHEMBL3545132
Mechanism of Action: BINDING AGENT
Max Phase: 4.0
Molecule Type: Antibody drug conjugate
First Approval: 2022

Molecule: MIRVETUXIMAB
ChEMBL ID: CHEMBL3545192
Mechanism of Action: BINDING AGENT
Max Phase: 2.0
Molecule Type: Antibody
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL4478):

Molecule: ZICONOTIDE ACETATE
ChEMBL ID: CHEMBL1795072
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Protein
First Approval: 2004

Molecule: LEVETIRACETAM
ChEMBL ID: CHEMBL1286
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1999

Molecule: ELPETRIGINE
ChEMBL ID: CHEMBL29919
Mechanism of Action: BLOCKER
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: CNV2197944
ChEMBL ID: CHEMBL5314401
Mechanism of Action: BLOCKER
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: Z160
ChEMBL ID: CHEMBL604710
Mechanism of Action: BLOCKER
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: RALFINAMIDE
ChEMBL ID: CHEMBL2107771
Mechanism of Action: BLOCKER
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: ZICONOTIDE
ChEMBL ID: CHEMBL4594214
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Protein
First Approval: 2004
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2524):

Molecule: MIGALASTAT
ChEMBL ID: CHEMBL110458
Mechanism of Action: STABILISER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2016

Molecule: MIGALASTAT HYDROCHLORIDE
ChEMBL ID: CHEMBL2107355
Mechanism of Action: STABILISER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2016
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2045):

Molecule: ACARBOSE
ChEMBL ID: CHEMBL1566
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Oligosaccharide
First Approval: 1995
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL278):

Molecule: UCB-1184197
ChEMBL ID: CHEMBL4297363
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2608):

Molecule: MIGLITOL
ChEMBL ID: CHEMBL1561
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1996

Molecule: DUVOGLUSTAT HYDROCHLORIDE
ChEMBL ID: CHEMBL460785
Mechanism of Action: STABILISER
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2850):

Molecule: LY-2090314
ChEMBL ID: CHEMBL362558
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2808):

Molecule: BMS-852927
ChEMBL ID: CHEMBL3945199
Mechanism of Action: MODULATOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: LXR-623
ChEMBL ID: CHEMBL456237
Mechanism of Action: AGONIST
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: CS-8080
ChEMBL ID: CHEMBL3545238
Mechanism of Action: AGONIST
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: HYODEOXYCHOLIC_ACID
ChEMBL ID: CHEMBL272621
Mechanism of Action: AGONIST
Max Phase: 1.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL4005):

Molecule: BAY-1082439
ChEMBL ID: CHEMBL3644672
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: FIMEPINOSTAT
ChEMBL ID: CHEMBL3622533
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: SERABELISIB
ChEMBL ID: CHEMBL3935857
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: PKI-179
ChEMBL ID: CHEMBL1258517
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: PWT-33579
ChEMBL ID: CHEMBL3545323
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: ALPELISIB
ChEMBL ID: CHEMBL2396661
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2019

Molecule: COPANLISIB HYDROCHLORIDE
ChEMBL ID: CHEMBL3545068
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2017

Molecule: COPANLISIB
ChEMBL ID: CHEMBL3218576
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2017

Molecule: INAVOLISIB
ChEMBL ID: CHEMBL4650215
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL1980):

Molecule: FLECAINIDE ACETATE
ChEMBL ID: CHEMBL1200822
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1985

Molecule: DIBUCAINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1200612
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1982

Molecule: RANOLAZINE
ChEMBL ID: CHEMBL1404
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2006

Molecule: AZD7009
ChEMBL ID: CHEMBL3545040
Mechanism of Action: BLOCKER
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: AZD1305
ChEMBL ID: CHEMBL3545169
Mechanism of Action: BLOCKER
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: PRENYLAMINE
ChEMBL ID: CHEMBL24072
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: VERNAKALANT HYDROCHLORIDE
ChEMBL ID: CHEMBL2107383
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2010
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3117):

Molecule: RSM-932A
ChEMBL ID: CHEMBL192986
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3045):

Molecule: ENZASTAURIN
ChEMBL ID: CHEMBL300138
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: RUBOXISTAURIN
ChEMBL ID: CHEMBL91829
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3955):

Molecule: PF-04605412
ChEMBL ID: CHEMBL2109622
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Antibody
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL4304):

Molecule: ANDOLAST
ChEMBL ID: CHEMBL119549
Mechanism of Action: ACTIVATOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: BMS-223131
ChEMBL ID: CHEMBL222460
Mechanism of Action: ACTIVATOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: FLINDOKALNER
ChEMBL ID: CHEMBL266510
Mechanism of Action: OPENER
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3896):

Molecule: MIROGABALIN BESYLATE
ChEMBL ID: CHEMBL3545257
Mechanism of Action: MODULATOR
Max Phase: -1.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL4445):

Molecule: VOCLOSPORIN
ChEMBL ID: CHEMBL5314379
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Protein
First Approval: 2021
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2007):

Molecule: AMUVATINIB
ChEMBL ID: CHEMBL2103851
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: OLARATUMAB
ChEMBL ID: CHEMBL1743049
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2016

Molecule: TOVETUMAB
ChEMBL ID: CHEMBL2364651
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: AVAPRITINIB
ChEMBL ID: CHEMBL4204794
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2020

Molecule: RIPRETINIB
ChEMBL ID: CHEMBL4216467
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2020

Molecule: SUNITINIB
ChEMBL ID: CHEMBL535
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2006
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL4703):

Molecule: LB-100
ChEMBL ID: CHEMBL4297300
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3660):

Molecule: IMGN-388
ChEMBL ID: CHEMBL2109633
Mechanism of Action: BINDING AGENT
Max Phase: 1.0
Molecule Type: Antibody drug conjugate
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL4282):

Molecule: BAY-1125976
ChEMBL ID: CHEMBL4751394
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: MSC-2363318A
ChEMBL ID: CHEMBL4871106
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: SR-13668
ChEMBL ID: CHEMBL245030
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL1974):

Molecule: SORAFENIB TOSYLATE
ChEMBL ID: CHEMBL1200485
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2005

Molecule: SUNITINIB MALATE
ChEMBL ID: CHEMBL1567
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2006

Molecule: ENMD-981693
ChEMBL ID: CHEMBL52885
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: SU-014813
ChEMBL ID: CHEMBL1721885
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: 4SC-203
ChEMBL ID: CHEMBL5314406
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: AS-602868
ChEMBL ID: CHEMBL129857
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: AST-487
ChEMBL ID: CHEMBL574738
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: CM-082
ChEMBL ID: CHEMBL3545427
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: CT-1578
ChEMBL ID: CHEMBL2035185
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: KW-2449
ChEMBL ID: CHEMBL1908397
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: ZOTIRACICLIB
ChEMBL ID: CHEMBL1944698
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: RG-1530
ChEMBL ID: CHEMBL1980391
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: CEP-2563 DIHYDROCHLORIDE
ChEMBL ID: CHEMBL5314390
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: AKN-028
ChEMBL ID: CHEMBL4790100
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: AT-9283
ChEMBL ID: CHEMBL495727
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: C-1311
ChEMBL ID: CHEMBL3545337
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: CRENOLANIB
ChEMBL ID: CHEMBL2105728
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: ENMD-2076
ChEMBL ID: CHEMBL482968
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: FORETINIB
ChEMBL ID: CHEMBL1230609
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: TANDUTINIB
ChEMBL ID: CHEMBL124660
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: AMUVATINIB
ChEMBL ID: CHEMBL2103851
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: PEXIDARTINIB
ChEMBL ID: CHEMBL3813873
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2019

Molecule: FAMITINIB
ChEMBL ID: CHEMBL1278146
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: XL-999
ChEMBL ID: CHEMBL5314391
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: GILTERITINIB
ChEMBL ID: CHEMBL3301622
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2018

Molecule: LINIFANIB
ChEMBL ID: CHEMBL223360
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: QUIZARTINIB
ChEMBL ID: CHEMBL576982
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2023

Molecule: LESTAURTINIB
ChEMBL ID: CHEMBL603469
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: MIDOSTAURIN
ChEMBL ID: CHEMBL608533
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2017

Molecule: FEDRATINIB
ChEMBL ID: CHEMBL1287853
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2019

Molecule: PACRITINIB
ChEMBL ID: CHEMBL2035187
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2022

Molecule: DOVITINIB
ChEMBL ID: CHEMBL522892
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: IMC-EB10
ChEMBL ID: CHEMBL2109328
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Antibody

Molecule: GILTERITINIB FUMARATE
ChEMBL ID: CHEMBL3301603
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2018

Molecule: PEXIDARTINIB HYDROCHLORIDE
ChEMBL ID: CHEMBL3989973
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2019

Molecule: FEDRATINIB HYDROCHLORIDE
ChEMBL ID: CHEMBL4297216
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2019

Molecule: RUSERONTINIB
ChEMBL ID: CHEMBL3678958
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: NINGETINIB
ChEMBL ID: CHEMBL3984441
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: AMG553
ChEMBL ID: CHEMBL4650295
Mechanism of Action: BINDING AGENT
Max Phase: 1.0
Molecule Type: Cell

Molecule: CDX-301
ChEMBL ID: CHEMBL4650387
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Protein

Molecule: FF-10101
ChEMBL ID: CHEMBL4650283
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: FLYSYN
ChEMBL ID: CHEMBL4650288
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Antibody

Molecule: PACRITINIB CITRATE
ChEMBL ID: CHEMBL5095049
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2022

Molecule: SUNITINIB
ChEMBL ID: CHEMBL535
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2006
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3026):

Molecule: AZD6280
ChEMBL ID: CHEMBL1783256
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: AZD7325
ChEMBL ID: CHEMBL1783282
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL4956):

Molecule: AZD6280
ChEMBL ID: CHEMBL1783256
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: AZD7325
ChEMBL ID: CHEMBL1783282
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: BROMAZEPAM
ChEMBL ID: CHEMBL277062
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL1844):

Molecule: PAZOPANIB HYDROCHLORIDE
ChEMBL ID: CHEMBL1201733
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2009

Molecule: SUNITINIB MALATE
ChEMBL ID: CHEMBL1567
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2006

Molecule: ARRY-382
ChEMBL ID: CHEMBL3644252
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: CT-1578
ChEMBL ID: CHEMBL2035185
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: EDICOTINIB
ChEMBL ID: CHEMBL3674570
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: PLX-5622
ChEMBL ID: CHEMBL3639728
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: PLX-7486
ChEMBL ID: CHEMBL3545381
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: ENMD-2076
ChEMBL ID: CHEMBL482968
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: PEXIDARTINIB
ChEMBL ID: CHEMBL3813873
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2019

Molecule: LINIFANIB
ChEMBL ID: CHEMBL223360
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: QUIZARTINIB
ChEMBL ID: CHEMBL576982
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2023

Molecule: VATALANIB
ChEMBL ID: CHEMBL101253
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: AMG-820
ChEMBL ID: CHEMBL2109322
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Antibody

Molecule: EMACTUZUMAB
ChEMBL ID: CHEMBL3545370
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody

Molecule: IMC-CS4
ChEMBL ID: CHEMBL2109323
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Antibody

Molecule: PEXIDARTINIB HYDROCHLORIDE
ChEMBL ID: CHEMBL3989973
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2019

Molecule: CABIRALIZUMAB
ChEMBL ID: CHEMBL4297713
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Antibody

Molecule: AXATILIMAB
ChEMBL ID: CHEMBL4594608
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: SERALUTINIB
ChEMBL ID: CHEMBL4650333
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: SUNITINIB
ChEMBL ID: CHEMBL535
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2006
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3522):

Molecule: ABIRATERONE ACETATE
ChEMBL ID: CHEMBL271227
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2011

Molecule: GALETERONE
ChEMBL ID: CHEMBL2105738
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: ORTERONEL
ChEMBL ID: CHEMBL1921976
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: ABIRATERONE
ChEMBL ID: CHEMBL254328
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: SEVITERONEL
ChEMBL ID: CHEMBL3264610
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: LEVOKETOCONAZOLE
ChEMBL ID: CHEMBL295698
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2021
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL4266):

Molecule: ELPETRIGINE
ChEMBL ID: CHEMBL29919
Mechanism of Action: BLOCKER
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2072):

Molecule: LEVOBUPIVACAINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1200749
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1999

Molecule: BUPIVACAINE
ChEMBL ID: CHEMBL1098
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1972

Molecule: BUPIVACAINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1200396
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1972

Molecule: RANOLAZINE
ChEMBL ID: CHEMBL1404
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2006
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL4296):

Molecule: AZD3161
ChEMBL ID: CHEMBL3545208
Mechanism of Action: BLOCKER
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: XEN403
ChEMBL ID: CHEMBL3545091
Mechanism of Action: BLOCKER
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: DSP-2230
ChEMBL ID: CHEMBL5095026
Mechanism of Action: BLOCKER
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: RG7893
ChEMBL ID: CHEMBL3707353
Mechanism of Action: BLOCKER
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: RG6029
ChEMBL ID: CHEMBL3707380
Mechanism of Action: BLOCKER
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: PF-05089771
ChEMBL ID: CHEMBL2325014
Mechanism of Action: BLOCKER
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: VIXOTRIGINE
ChEMBL ID: CHEMBL3544913
Mechanism of Action: BLOCKER
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL4187):

Molecule: ELPETRIGINE
ChEMBL ID: CHEMBL29919
Mechanism of Action: BLOCKER
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL5163):

Molecule: ELPETRIGINE
ChEMBL ID: CHEMBL29919
Mechanism of Action: BLOCKER
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL5202):

Molecule: ZANDATRIGINE
ChEMBL ID: CHEMBL4650313
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL5451):

Molecule: DIBUCAINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1200612
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1982

Molecule: DSP-2230
ChEMBL ID: CHEMBL5095026
Mechanism of Action: BLOCKER
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: AFACIFENACIN
ChEMBL ID: CHEMBL3545165
Mechanism of Action: BLOCKER
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: PF-04531083
ChEMBL ID: CHEMBL3589904
Mechanism of Action: BLOCKER
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL4917):

Molecule: AL-78898A
ChEMBL ID: CHEMBL4594457
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Unknown

Molecule: PEGCETACOPLAN
ChEMBL ID: CHEMBL4298211
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Protein
First Approval: 2021

Molecule: AMY-101
ChEMBL ID: CHEMBL4297260
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Protein
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL4998):

Molecule: VATELIZUMAB
ChEMBL ID: CHEMBL1743086
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Antibody
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL6152):

Molecule: CINPANEMAB
ChEMBL ID: CHEMBL3833330
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: PRASINEZUMAB
ChEMBL ID: CHEMBL4298077
Mechanism of Action: BINDING AGENT
Max Phase: 2.0
Molecule Type: Antibody
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL1907598):

Molecule: ABCIXIMAB
ChEMBL ID: CHEMBL1201584
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 1993

Molecule: CILENGITIDE
ChEMBL ID: CHEMBL429876
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Protein

Molecule: ABITUZUMAB
ChEMBL ID: CHEMBL2109621
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: ETARACIZUMAB
ChEMBL ID: CHEMBL5314357
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Antibody

Molecule: INTETUMUMAB
ChEMBL ID: CHEMBL1743032
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Antibody

Molecule: ATN-161
ChEMBL ID: CHEMBL4297456
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Protein
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2093866):

Molecule: ESTROGENS, ESTERIFIED
ChEMBL ID: CHEMBL1201468
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Unknown
First Approval: 1977

Molecule: ESTROGENS, CONJUGATED SYNTHETIC A
ChEMBL ID: CHEMBL1201466
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1999

Molecule: ESTROGENS, CONJUGATED
ChEMBL ID: CHEMBL1201649
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Unknown
First Approval: 1942

Molecule: SYNTHETIC CONJUGATED ESTROGENS, B
ChEMBL ID: CHEMBL1201467
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2004

Molecule: OSPEMIFENE
ChEMBL ID: CHEMBL2105395
Mechanism of Action: MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2013

Molecule: DIETHYLSTILBESTROL DIPHOSPHATE
ChEMBL ID: CHEMBL1200598
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1982

Molecule: QUINESTROL
ChEMBL ID: CHEMBL1201165
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1982

Molecule: FULVESTRANT
ChEMBL ID: CHEMBL1358
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2002

Molecule: TOREMIFENE CITRATE
ChEMBL ID: CHEMBL1200675
Mechanism of Action: MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1996

Molecule: BAZEDOXIFENE ACETATE
ChEMBL ID: CHEMBL2106615
Mechanism of Action: MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2009

Molecule: CHF4227
ChEMBL ID: CHEMBL3545355
Mechanism of Action: MODULATOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: FISPEMIFENE
ChEMBL ID: CHEMBL2107341
Mechanism of Action: MODULATOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: LY2245461
ChEMBL ID: CHEMBL3545389
Mechanism of Action: MODULATOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: IDOXIFENE
ChEMBL ID: CHEMBL6318
Mechanism of Action: MODULATOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: MK-6913
ChEMBL ID: CHEMBL3545274
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: AFIMOXIFENE
ChEMBL ID: CHEMBL489
Mechanism of Action: MODULATOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: DROLOXIFENE
ChEMBL ID: CHEMBL487
Mechanism of Action: MODULATOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: ACOLBIFENE
ChEMBL ID: CHEMBL68055
Mechanism of Action: MODULATOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: ARZOXIFENE
ChEMBL ID: CHEMBL226267
Mechanism of Action: MODULATOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: CYCLOFENIL
ChEMBL ID: CHEMBL141305
Mechanism of Action: MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: ALLYLESTRENOL
ChEMBL ID: CHEMBL2105618
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: ESTRIOL
ChEMBL ID: CHEMBL193482
Mechanism of Action: MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2000

Molecule: LASOFOXIFENE
ChEMBL ID: CHEMBL328190
Mechanism of Action: MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2009

Molecule: ESTETROL
ChEMBL ID: CHEMBL1230314
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2021

Molecule: LASOFOXIFENE TARTRATE
ChEMBL ID: CHEMBL5315115
Mechanism of Action: MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2009
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2093869):

Molecule: ABCIXIMAB
ChEMBL ID: CHEMBL1201584
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 1993

Molecule: EPTIFIBATIDE
ChEMBL ID: CHEMBL1174
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Protein
First Approval: 1998

Molecule: TIROFIBAN HYDROCHLORIDE
ChEMBL ID: CHEMBL3189072
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1998

Molecule: TADOCIZUMAB
ChEMBL ID: CHEMBL1743076
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Antibody

Molecule: ZALUNFIBAN
ChEMBL ID: CHEMBL3114577
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2094108):

Molecule: TIPIFARNIB
ChEMBL ID: CHEMBL289228
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: LONAFARNIB
ChEMBL ID: CHEMBL298734
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2020
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2094118):

Molecule: CARVEDILOL
ChEMBL ID: CHEMBL723
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1995

Molecule: CARVEDILOL PHOSPHATE
ChEMBL ID: CHEMBL1201167
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2006

Molecule: ISOPROTERENOL SULFATE
ChEMBL ID: CHEMBL3989521
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1956

Molecule: CARTEOLOL HYDROCHLORIDE
ChEMBL ID: CHEMBL1201002
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1988

Molecule: ISOPROTERENOL HYDROCHLORIDE
ChEMBL ID: CHEMBL1711
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1956

Molecule: DILEVALOL HYDROCHLORIDE
ChEMBL ID: CHEMBL1204165
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1990
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2095168):

Molecule: EFAPROXIRAL
ChEMBL ID: CHEMBL18901
Mechanism of Action: NEGATIVE MODULATOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: VOXELOTOR
ChEMBL ID: CHEMBL4101807
Mechanism of Action: POSITIVE MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2019
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2095182):

Molecule: TRASTUZUMAB EMTANSINE
ChEMBL ID: CHEMBL1743082
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody drug conjugate
First Approval: 2013

Molecule: BRENTUXIMAB VEDOTIN
ChEMBL ID: CHEMBL1742994
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody drug conjugate
First Approval: 2011

Molecule: PACLITAXEL
ChEMBL ID: CHEMBL428647
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1992

Molecule: DOCETAXEL
ChEMBL ID: CHEMBL3545252
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1996

Molecule: ERIBULIN MESYLATE
ChEMBL ID: CHEMBL1683544
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2010

Molecule: CABAZITAXEL
ChEMBL ID: CHEMBL1201748
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2010

Molecule: COLCHICINE
ChEMBL ID: CHEMBL107
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1961

Molecule: IXABEPILONE
ChEMBL ID: CHEMBL1201752
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2007

Molecule: VINCRISTINE SULFATE
ChEMBL ID: CHEMBL501867
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1963

Molecule: VINORELBINE TARTRATE
ChEMBL ID: CHEMBL538943
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1994

Molecule: VINBLASTINE SULFATE
ChEMBL ID: CHEMBL378544
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1965

Molecule: PACLITAXEL POLIGLUMEX
ChEMBL ID: CHEMBL2108628
Mechanism of Action: STABILISER
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: INDIBULIN
ChEMBL ID: CHEMBL49642
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: DAVUNETIDE
ChEMBL ID: CHEMBL2103826
Mechanism of Action: STABILISER
Max Phase: 2.0
Molecule Type: Protein

Molecule: CROLIBULIN
ChEMBL ID: CHEMBL2103852
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: LEXIBULIN
ChEMBL ID: CHEMBL552212
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: VINFLUNINE
ChEMBL ID: CHEMBL2110725
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2009

Molecule: FOSBRETABULIN DISODIUM
ChEMBL ID: CHEMBL289351
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: FOSBRETABULIN TROMETHAMINE
ChEMBL ID: CHEMBL2105643
Mechanism of Action: DISRUPTING AGENT
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: SAGOPILONE
ChEMBL ID: CHEMBL2304041
Mechanism of Action: STABILISER
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: PLINABULIN
ChEMBL ID: CHEMBL1096380
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: VERUBULIN
ChEMBL ID: CHEMBL492399
Mechanism of Action: DISRUPTING AGENT
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: MIRVETUXIMAB SORAVTANSINE
ChEMBL ID: CHEMBL3545132
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody drug conjugate
First Approval: 2022

Molecule: POLATUZUMAB VEDOTIN
ChEMBL ID: CHEMBL3301582
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody drug conjugate
First Approval: 2019

Molecule: RG-7841
ChEMBL ID: CHEMBL4297935
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Unknown

Molecule: PF-06263507
ChEMBL ID: CHEMBL4297804
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Unknown

Molecule: AZINTUXIZUMAB VEDOTIN
ChEMBL ID: CHEMBL4297859
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody drug conjugate

Molecule: ENAPOTAMAB VEDOTIN
ChEMBL ID: CHEMBL4297987
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody drug conjugate

Molecule: INDUSATUMAB VEDOTIN
ChEMBL ID: CHEMBL4298045
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody drug conjugate

Molecule: LADIRATUZUMAB VEDOTIN
ChEMBL ID: CHEMBL4298101
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody drug conjugate

Molecule: LIFASTUZUMAB VEDOTIN
ChEMBL ID: CHEMBL4297938
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody drug conjugate

Molecule: TELISOTUZUMAB VEDOTIN
ChEMBL ID: CHEMBL3990032
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody drug conjugate

Molecule: TISOTUMAB VEDOTIN
ChEMBL ID: CHEMBL4297841
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody drug conjugate
First Approval: 2021

Molecule: BELANTAMAB MAFODOTIN
ChEMBL ID: CHEMBL4298209
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody drug conjugate
First Approval: 2020

Molecule: BMS-275183
ChEMBL ID: CHEMBL4297268
Mechanism of Action: STABILISER
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: DOLASTATIN-10
ChEMBL ID: CHEMBL39541
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: EPOTHILONE D
ChEMBL ID: CHEMBL96172
Mechanism of Action: STABILISER
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: KOS-1584
ChEMBL ID: CHEMBL4297296
Mechanism of Action: STABILISER
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: LAROTAXEL
ChEMBL ID: CHEMBL4279455
Mechanism of Action: STABILISER
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: PACLITAXEL DOCOSAHEXAENOIC ACID
ChEMBL ID: CHEMBL4297441
Mechanism of Action: STABILISER
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: AGS-16C3F
ChEMBL ID: CHEMBL4594455
Mechanism of Action: DISRUPTING AGENT
Max Phase: 2.0
Molecule Type: Unknown

Molecule: PATUPILONE
ChEMBL ID: CHEMBL94657
Mechanism of Action: STABILISER
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: TUSAMITAMAB RAVTANSINE
ChEMBL ID: CHEMBL4298098
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody drug conjugate

Molecule: ANG1005
ChEMBL ID: CHEMBL1089636
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Protein

Molecule: APRUTUMAB IXADOTIN
ChEMBL ID: CHEMBL4650293
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Antibody drug conjugate

Molecule: ASG-5ME
ChEMBL ID: CHEMBL2109574
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Antibody drug conjugate

Molecule: ENFORTUMAB VEDOTIN
ChEMBL ID: CHEMBL3301589
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody drug conjugate
First Approval: 2019

Molecule: GLEMBATUMUMAB VEDOTIN
ChEMBL ID: CHEMBL1743028
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody drug conjugate

Molecule: PINATUZUMAB VEDOTIN
ChEMBL ID: CHEMBL3301585
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody drug conjugate

Molecule: RG-7600
ChEMBL ID: CHEMBL2109281
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Antibody drug conjugate

Molecule: RG-7636
ChEMBL ID: CHEMBL2109282
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Antibody drug conjugate

Molecule: SOFITUZUMAB VEDOTIN
ChEMBL ID: CHEMBL3545372
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody drug conjugate

Molecule: VANDORTUZUMAB VEDOTIN
ChEMBL ID: CHEMBL3833306
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody drug conjugate

Molecule: T-900607
ChEMBL ID: CHEMBL4297440
Mechanism of Action: DISRUPTING AGENT
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: LORVOTUZUMAB MERTANSINE
ChEMBL ID: CHEMBL1743037
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody drug conjugate

Molecule: CANTUZUMAB MERTANSINE
ChEMBL ID: CHEMBL1742997
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody drug conjugate

Molecule: BIVATUZUMAB MERTANSINE
ChEMBL ID: CHEMBL2109288
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Antibody drug conjugate

Molecule: PRALUZATAMAB RAVTANSINE
ChEMBL ID: CHEMBL4297736
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody drug conjugate

Molecule: ANVATABART OPADOTIN
ChEMBL ID: CHEMBL4297892
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody drug conjugate

Molecule: MILATAXEL
ChEMBL ID: CHEMBL2107759
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: OMBRABULIN
ChEMBL ID: CHEMBL572284
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: SOBLIDOTIN
ChEMBL ID: CHEMBL3989512
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: PLOCABULIN
ChEMBL ID: CHEMBL4297636
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: VINFLUNINE DITARTRATE
ChEMBL ID: CHEMBL2105629
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2009
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2095184):

Molecule: NATALIZUMAB
ChEMBL ID: CHEMBL1201607
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2004

Molecule: VEDOLIZUMAB
ChEMBL ID: CHEMBL1743087
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2014

Molecule: FIRATEGRAST
ChEMBL ID: CHEMBL2104967
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: ABRILUMAB
ChEMBL ID: CHEMBL3137351
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2095186):

Molecule: DESLANOSIDE
ChEMBL ID: CHEMBL1614
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1982

Molecule: DIGITOXIN
ChEMBL ID: CHEMBL254219
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1982

Molecule: DIGOXIN
ChEMBL ID: CHEMBL1751
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1975

Molecule: ACETYLDIGITOXIN
ChEMBL ID: CHEMBL3545057
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1982

Molecule: ISTAROXIME
ChEMBL ID: CHEMBL2093999
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: LANATOSIDE C
ChEMBL ID: CHEMBL506569
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2095189):

Molecule: BECAPLERMIN
ChEMBL ID: CHEMBL1201556
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 1997

Molecule: PAZOPANIB HYDROCHLORIDE
ChEMBL ID: CHEMBL1201733
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2009

Molecule: REGORAFENIB
ChEMBL ID: CHEMBL1946170
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2012

Molecule: SUNITINIB MALATE
ChEMBL ID: CHEMBL1567
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2006

Molecule: NINTEDANIB ESYLATE
ChEMBL ID: CHEMBL3039504
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2014

Molecule: ENMD-981693
ChEMBL ID: CHEMBL52885
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: SU-014813
ChEMBL ID: CHEMBL1721885
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: ILORASERTIB
ChEMBL ID: CHEMBL1980297
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: TAK-593
ChEMBL ID: CHEMBL2180604
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: CRENOLANIB
ChEMBL ID: CHEMBL2105728
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: FORETINIB
ChEMBL ID: CHEMBL1230609
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: FAMITINIB
ChEMBL ID: CHEMBL1278146
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: X-82
ChEMBL ID: CHEMBL3545401
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: XL-820
ChEMBL ID: CHEMBL3545402
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: XL-999
ChEMBL ID: CHEMBL5314391
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: MASITINIB
ChEMBL ID: CHEMBL1908391
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2008

Molecule: LINIFANIB
ChEMBL ID: CHEMBL223360
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: QUIZARTINIB
ChEMBL ID: CHEMBL576982
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2023

Molecule: CEDIRANIB
ChEMBL ID: CHEMBL491473
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: MIDOSTAURIN
ChEMBL ID: CHEMBL608533
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2017

Molecule: VATALANIB
ChEMBL ID: CHEMBL101253
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: ORANTINIB
ChEMBL ID: CHEMBL274654
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: DOVITINIB
ChEMBL ID: CHEMBL522892
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: MOTESANIB
ChEMBL ID: CHEMBL572881
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: SERALUTINIB
ChEMBL ID: CHEMBL4650333
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2095226):

Molecule: VOLOCIXIMAB
ChEMBL ID: CHEMBL2108061
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Antibody

Molecule: ATN-161
ChEMBL ID: CHEMBL4297456
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Protein
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2095229):

Molecule: CLEVIDIPINE
ChEMBL ID: CHEMBL1237132
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2008

Molecule: ISRADIPINE
ChEMBL ID: CHEMBL1648
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1990

Molecule: DILTIAZEM HYDROCHLORIDE
ChEMBL ID: CHEMBL1697
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1982

Molecule: DRONEDARONE HYDROCHLORIDE
ChEMBL ID: CHEMBL1201729
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2009

Molecule: AMLODIPINE MALEATE
ChEMBL ID: CHEMBL1200984
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2003

Molecule: VERAPAMIL HYDROCHLORIDE
ChEMBL ID: CHEMBL1280
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1981

Molecule: NIFEDIPINE
ChEMBL ID: CHEMBL193
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1981

Molecule: DILTIAZEM MALATE
ChEMBL ID: CHEMBL1200805
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1996

Molecule: AMLODIPINE BESYLATE
ChEMBL ID: CHEMBL1200402
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1992

Molecule: NICARDIPINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1200326
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1988

Molecule: NIMODIPINE
ChEMBL ID: CHEMBL1428
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1988

Molecule: NISOLDIPINE
ChEMBL ID: CHEMBL1726
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1995

Molecule: FELODIPINE
ChEMBL ID: CHEMBL1480
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1991

Molecule: ELPETRIGINE
ChEMBL ID: CHEMBL29919
Mechanism of Action: BLOCKER
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: AZD1305
ChEMBL ID: CHEMBL3545169
Mechanism of Action: BLOCKER
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: CINNARIZINE
ChEMBL ID: CHEMBL43064
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: AMLODIPINE BENZOATE
ChEMBL ID: CHEMBL4594262
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2019

Molecule: LEVAMLODIPINE MALEATE
ChEMBL ID: CHEMBL4594288
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2019

Molecule: AZELNIDIPINE
ChEMBL ID: CHEMBL1275868
Mechanism of Action: BLOCKER
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: BARNIDIPINE
ChEMBL ID: CHEMBL2103761
Mechanism of Action: BLOCKER
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: NITRENDIPINE
ChEMBL ID: CHEMBL475534
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: BENIDIPINE
ChEMBL ID: CHEMBL2074972
Mechanism of Action: BLOCKER
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: MANIDIPINE 6300
ChEMBL ID: CHEMBL1085699
Mechanism of Action: BLOCKER
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: NILVADIPINE
ChEMBL ID: CHEMBL517427
Mechanism of Action: BLOCKER
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: CILNIDIPINE
ChEMBL ID: CHEMBL452076
Mechanism of Action: BLOCKER
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: LERCANIDIPINE HYDROCHLORIDE
ChEMBL ID: CHEMBL2106419
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: LACIDIPINE
ChEMBL ID: CHEMBL460291
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2096675):

Molecule: CILENGITIDE
ChEMBL ID: CHEMBL429876
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Protein

Molecule: ABITUZUMAB
ChEMBL ID: CHEMBL2109621
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: INTETUMUMAB
ChEMBL ID: CHEMBL1743032
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Antibody
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2109244):

Molecule: GABOXADOL
ChEMBL ID: CHEMBL312443
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: ZOPICLONE
ChEMBL ID: CHEMBL135400
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2111416):

Molecule: ABITUZUMAB
ChEMBL ID: CHEMBL2109621
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: STX-100
ChEMBL ID: CHEMBL2109623
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2111407):

Molecule: ABITUZUMAB
ChEMBL ID: CHEMBL2109621
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2331043):

Molecule: QUINIDINE POLYGALACTURONATE
ChEMBL ID: CHEMBL1201486
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1982

Molecule: ROPIVACAINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1889140
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1996

Molecule: PHENACEMIDE
ChEMBL ID: CHEMBL918
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1951

Molecule: BENOXINATE HYDROCHLORIDE
ChEMBL ID: CHEMBL1200654
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1982

Molecule: CHLOROPROCAINE HYDROCHLORIDE
ChEMBL ID: CHEMBL944
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1955

Molecule: MEXILETINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1200606
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1985

Molecule: RILUZOLE
ChEMBL ID: CHEMBL744
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1995

Molecule: HEXYLCAINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1200715
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1982

Molecule: PHENAZOPYRIDINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1201022
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1987

Molecule: QUINIDINE GLUCONATE
ChEMBL ID: CHEMBL1200437
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1950

Molecule: PRIMIDONE
ChEMBL ID: CHEMBL856
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1954

Molecule: ETHOTOIN
ChEMBL ID: CHEMBL1095
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1957

Molecule: DISOPYRAMIDE PHOSPHATE
ChEMBL ID: CHEMBL1201020
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1977

Molecule: DRONEDARONE HYDROCHLORIDE
ChEMBL ID: CHEMBL1201729
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2009

Molecule: DYCLONINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1200478
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1982

Molecule: QUINIDINE SULFATE
ChEMBL ID: CHEMBL3707183
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1962

Molecule: PRILOCAINE
ChEMBL ID: CHEMBL1194
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1965

Molecule: PHENYTOIN SODIUM
ChEMBL ID: CHEMBL1611
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1956

Molecule: TOPIRAMATE
ChEMBL ID: CHEMBL220492
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1996

Molecule: MERETHOXYLLINE PROCAINE
ChEMBL ID: CHEMBL1200443
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: PROCAINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1200841
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1954

Molecule: MEPHENYTOIN
ChEMBL ID: CHEMBL861
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1946

Molecule: CARBAMAZEPINE
ChEMBL ID: CHEMBL108
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1968

Molecule: ARTICAINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1200819
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2000

Molecule: TETRACAINE
ChEMBL ID: CHEMBL698
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2005

Molecule: LACOSAMIDE
ChEMBL ID: CHEMBL58323
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2008

Molecule: MEPIVACAINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1200440
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1960

Molecule: MORICIZINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1200334
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1990

Molecule: ETIDOCAINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1200597
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1976

Molecule: ORPHENADRINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1201023
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1957

Molecule: ORPHENADRINE CITRATE
ChEMBL ID: CHEMBL1200395
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1959

Molecule: PROCAINAMIDE HYDROCHLORIDE
ChEMBL ID: CHEMBL605
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1950

Molecule: PROPAFENONE HYDROCHLORIDE
ChEMBL ID: CHEMBL1201063
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1989

Molecule: PROPARACAINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1200464
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1953

Molecule: PROPOXYCAINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1769
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1982

Molecule: RUFINAMIDE
ChEMBL ID: CHEMBL1201754
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2007

Molecule: OXCARBAZEPINE
ChEMBL ID: CHEMBL1068
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2000

Molecule: PHENYTOIN
ChEMBL ID: CHEMBL16
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1953

Molecule: PRILOCAINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1200586
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1965

Molecule: FOSPHENYTOIN SODIUM
ChEMBL ID: CHEMBL919
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1996

Molecule: INDECAINIDE HYDROCHLORIDE
ChEMBL ID: CHEMBL1200341
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1989

Molecule: LAMOTRIGINE
ChEMBL ID: CHEMBL741
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1994

Molecule: LIDOCAINE
ChEMBL ID: CHEMBL79
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1948

Molecule: LIDOCAINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1200409
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1948

Molecule: TOCAINIDE HYDROCHLORIDE
ChEMBL ID: CHEMBL1200773
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1984

Molecule: ZONISAMIDE
ChEMBL ID: CHEMBL750
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2000

Molecule: ESLICARBAZEPINE ACETATE
ChEMBL ID: CHEMBL87992
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2009

Molecule: EVENAMIDE
ChEMBL ID: CHEMBL3678076
Mechanism of Action: BLOCKER
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: NKTR-171
ChEMBL ID: CHEMBL3545209
Mechanism of Action: BLOCKER
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: IRAMPANEL
ChEMBL ID: CHEMBL29741
Mechanism of Action: BLOCKER
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: NERISPIRDINE
ChEMBL ID: CHEMBL2107762
Mechanism of Action: BLOCKER
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: RALFINAMIDE
ChEMBL ID: CHEMBL2107771
Mechanism of Action: BLOCKER
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: TETRACAINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1255654
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2016

Molecule: ESLICARBAZEPINE
ChEMBL ID: CHEMBL315985
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: ENCAINIDE HYDROCHLORIDE
ChEMBL ID: CHEMBL2106155
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1986

Molecule: DICHLOROBENZYL ALCOHOL
ChEMBL ID: CHEMBL3184437
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: CENOBAMATE
ChEMBL ID: CHEMBL3989949
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2020

Molecule: COCAINE HYDROCHLORIDE
ChEMBL ID: CHEMBL529437
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2017
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2362995):

Molecule: PHENSUXIMIDE
ChEMBL ID: CHEMBL797
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1982

Molecule: PARAMETHADIONE
ChEMBL ID: CHEMBL1100
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1949

Molecule: METHSUXIMIDE
ChEMBL ID: CHEMBL697
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1957

Molecule: ETHOSUXIMIDE
ChEMBL ID: CHEMBL696
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1960

Molecule: TRIMETHADIONE
ChEMBL ID: CHEMBL695
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1946

Molecule: MIBEFRADIL DIHYDROCHLORIDE
ChEMBL ID: CHEMBL1534525
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1997

Molecule: APINOCALTAMIDE
ChEMBL ID: CHEMBL4217292
Mechanism of Action: BLOCKER
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: SUVECALTAMIDE
ChEMBL ID: CHEMBL1684950
Mechanism of Action: MODULATOR
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2363075):

Molecule: DUTASTERIDE
ChEMBL ID: CHEMBL1200969
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2001

Molecule: ABIRATERONE
ChEMBL ID: CHEMBL254328
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2364023):

Molecule: SPINOSAD
ChEMBL ID: CHEMBL4297065
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2011
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2364155):

Molecule: TOCILIZUMAB
ChEMBL ID: CHEMBL1237022
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2005

Molecule: SARILUMAB
ChEMBL ID: CHEMBL2108730
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2017

Molecule: VOBARILIZUMAB
ChEMBL ID: CHEMBL3833343
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: LEVILIMAB
ChEMBL ID: CHEMBL4650406
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2364163):

Molecule: ECULIZUMAB
ChEMBL ID: CHEMBL1201828
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2007

Molecule: PEXELIZUMAB
ChEMBL ID: CHEMBL2107979
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody

Molecule: VILOBELIMAB
ChEMBL ID: CHEMBL2109636
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: RAVULIZUMAB
ChEMBL ID: CHEMBL3989986
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2018

Molecule: TESIDOLUMAB
ChEMBL ID: CHEMBL4298012
Mechanism of Action: BINDING AGENT
Max Phase: 2.0
Molecule Type: Antibody

Molecule: NOMACOPAN
ChEMBL ID: CHEMBL4297928
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Unknown

Molecule: OLENDALIZUMAB
ChEMBL ID: CHEMBL3990025
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: POZELIMAB
ChEMBL ID: CHEMBL4298086
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2023

Molecule: ZILUCOPLAN
ChEMBL ID: CHEMBL4298207
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Protein

Molecule: CROVALIMAB
ChEMBL ID: CHEMBL4594316
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody

Molecule: ZILUCOPLAN SODIUM
ChEMBL ID: CHEMBL5315048
Mechanism of Action: BINDING AGENT
Max Phase: 4.0
Molecule Type: Protein
First Approval: 2023
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2364169):

Molecule: SARGRAMOSTIM
ChEMBL ID: CHEMBL1201670
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 1991

Molecule: MAVRILIMUMAB
ChEMBL ID: CHEMBL1743039
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Antibody
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2364170):

Molecule: INTERFERON ALFA-N3
ChEMBL ID: CHEMBL2109047
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 1989

Molecule: INTERFERON ALFA-2A
ChEMBL ID: CHEMBL2108508
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 1986

Molecule: INTERFERON ALFA-2B
ChEMBL ID: CHEMBL1201558
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 1986

Molecule: INTERFERON BETA-1A
ChEMBL ID: CHEMBL1201562
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 1996

Molecule: PEGINTERFERON ALFA-2A
ChEMBL ID: CHEMBL1201560
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 2002

Molecule: PEGINTERFERON ALFA-2B
ChEMBL ID: CHEMBL1201561
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 2000

Molecule: INTERFERON BETA-1B
ChEMBL ID: CHEMBL1201563
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 1993

Molecule: INTERFERON ALFACON-1
ChEMBL ID: CHEMBL1201557
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 1997

Molecule: PEGINTERFERON BETA-1A
ChEMBL ID: CHEMBL2108677
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 2014

Molecule: ALBINTERFERON ALFA-2B
ChEMBL ID: CHEMBL2107842
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Protein

Molecule: ROPEGINTERFERON ALFA-2B
ChEMBL ID: CHEMBL4297819
Mechanism of Action: POSITIVE MODULATOR
Max Phase: 4.0
Molecule Type: Unknown
First Approval: 2019
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2364187):

Molecule: OCRIPLASMIN
ChEMBL ID: CHEMBL2095222
Mechanism of Action: HYDROLYTIC ENZYME
Max Phase: 4.0
Molecule Type: Protein
First Approval: 2010
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2364703):

Molecule: GRISEOFULVIN
ChEMBL ID: CHEMBL562
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1962
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2364705):

Molecule: ALBENDAZOLE
ChEMBL ID: CHEMBL1483
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1996

Molecule: MEBENDAZOLE
ChEMBL ID: CHEMBL685
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1974

Molecule: THIABENDAZOLE
ChEMBL ID: CHEMBL625
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1967

Molecule: OXFENDAZOLE
ChEMBL ID: CHEMBL42442
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3038461):

Molecule: POZANICLINE
ChEMBL ID: CHEMBL127071
Mechanism of Action: PARTIAL AGONIST
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3137266):

Molecule: SATRALIZUMAB
ChEMBL ID: CHEMBL3833307
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2020
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3390825):

Molecule: ISAVUCONAZONIUM SULFATE
ChEMBL ID: CHEMBL3137333
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2015
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3430892):

Molecule: ABITUZUMAB
ChEMBL ID: CHEMBL2109621
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3580483):

Molecule: BENRALIZUMAB
ChEMBL ID: CHEMBL1742991
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2017
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3580490):

Molecule: DUPILUMAB
ChEMBL ID: CHEMBL2108675
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2017
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3580496):

Molecule: BERMEKIMAB
ChEMBL ID: CHEMBL2109653
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody

Molecule: LUTIKIZUMAB
ChEMBL ID: CHEMBL4594518
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3712987):

Molecule: CSL-360
ChEMBL ID: CHEMBL2109327
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Antibody

Molecule: TAGRAXOFUSP
ChEMBL ID: CHEMBL4297573
Mechanism of Action: BINDING AGENT
Max Phase: 4.0
Molecule Type: Protein
First Approval: 2018

Molecule: FLOTETUZUMAB
ChEMBL ID: CHEMBL3990038
Mechanism of Action: BINDING AGENT
Max Phase: 2.0
Molecule Type: Antibody

Molecule: TALACOTUZUMAB
ChEMBL ID: CHEMBL4297837
Mechanism of Action: BINDING AGENT
Max Phase: 2.0
Molecule Type: Antibody
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3713007):

Molecule: FARALIMOMAB
ChEMBL ID: CHEMBL2108407
Mechanism of Action: BINDING AGENT
Max Phase: 2.0
Molecule Type: Antibody
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3713941):

Molecule: CINTREDEKIN BESUDOTOX
ChEMBL ID: CHEMBL2108583
Mechanism of Action: BINDING AGENT
Max Phase: 3.0
Molecule Type: Protein
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3831285):

Molecule: CINTREDEKIN BESUDOTOX
ChEMBL ID: CHEMBL2108583
Mechanism of Action: BINDING AGENT
Max Phase: 3.0
Molecule Type: Protein
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3833481):

Molecule: LIATERMIN
ChEMBL ID: CHEMBL2108380
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Protein
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3833502):

Molecule: VOGLIBOSE
ChEMBL ID: CHEMBL476960
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1994

Molecule: CELGOSIVIR
ChEMBL ID: CHEMBL2110737
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3988505):

Molecule: TRC-093
ChEMBL ID: CHEMBL2109374
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Antibody
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL4295690):

Molecule: TECHNETIUM TC 99M SUCCIMER
ChEMBL ID: CHEMBL1200797
Mechanism of Action: BINDING AGENT
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1982
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL4630894):

Molecule: NEMOLIZUMAB
ChEMBL ID: CHEMBL4297794
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL4662938):

Molecule: FEPIXNEBART
ChEMBL ID: CHEMBL4594573
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL5303559):

Molecule: TASIPIMIDINE SULFATE
ChEMBL ID: CHEMBL4594268
Mechanism of Action: AGONIST
Max Phase: 1.0
Molecule Type: Small molecule
First Approval: 2021
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2074):

Molecule: MIGLITOL
ChEMBL ID: CHEMBL1561
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1996

Molecule: ACARBOSE
ChEMBL ID: CHEMBL1566
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Oligosaccharide
First Approval: 1995
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL1859):

Molecule: ABT-639
ChEMBL ID: CHEMBL3590674
Mechanism of Action: BLOCKER
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL1981):

Molecule: INSULIN SUSP ISOPHANE RECOMBINANT HUMAN
ChEMBL ID: CHEMBL1201540
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 1982

Molecule: INSULIN PURIFIED BEEF
ChEMBL ID: CHEMBL1201629
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 1980

Molecule: INSULIN ZINC SUSP RECOMBINANT HUMAN
ChEMBL ID: CHEMBL1201644
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 1985

Molecule: INSULIN ZINC SUSP BEEF
ChEMBL ID: CHEMBL1201639
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 1982

Molecule: INSULIN ZINC SUSP EXTENDED PURIFIED BEEF
ChEMBL ID: CHEMBL1201542
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 1982

Molecule: INSULIN ZINC SUSP SEMISYNTHETIC PURIFIED HUMAN
ChEMBL ID: CHEMBL1201543
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 1983

Molecule: INSULIN HUMAN
ChEMBL ID: CHEMBL1201631
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 1982

Molecule: INSULIN SUSP ISOPHANE PURIFIED PORK
ChEMBL ID: CHEMBL1201656
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 1979

Molecule: INSULIN ZINC SUSP PURIFIED PORK
ChEMBL ID: CHEMBL1201653
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 1979

Molecule: INSULIN SUSP ISOPHANE BEEF/PORK
ChEMBL ID: CHEMBL1201635
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 1966

Molecule: INSULIN SUSP PROTAMINE ZINC BEEF/PORK
ChEMBL ID: CHEMBL1201628
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 1966

Molecule: INSULIN PURIFIED PORK
ChEMBL ID: CHEMBL1201630
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 1979

Molecule: INSULIN SUSP ISOPHANE BEEF
ChEMBL ID: CHEMBL1201545
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 1982

Molecule: INSULIN SUSP PROTAMINE ZINC PURIFIED PORK
ChEMBL ID: CHEMBL1201638
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 1979

Molecule: INSULIN LISPRO PROTAMINE RECOMBINANT
ChEMBL ID: CHEMBL1201611
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 1999

Molecule: INSULIN ZINC SUSP PURIFIED BEEF/PORK
ChEMBL ID: CHEMBL1201634
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 1982

Molecule: INSULIN LISPRO
ChEMBL ID: CHEMBL1201538
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 1996

Molecule: INSULIN GLULISINE
ChEMBL ID: CHEMBL1201613
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 2004

Molecule: INSULIN ZINC SUSP PROMPT BEEF
ChEMBL ID: CHEMBL1201642
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 1982

Molecule: INSULIN GLARGINE
ChEMBL ID: CHEMBL1201497
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 2000

Molecule: INSULIN PORK
ChEMBL ID: CHEMBL1201539
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 1966

Molecule: INSULIN ZINC SUSP EXTENDED BEEF
ChEMBL ID: CHEMBL1201640
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 1982

Molecule: INSULIN SUSP ISOPHANE PURIFIED BEEF
ChEMBL ID: CHEMBL1201655
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 1980

Molecule: INSULIN SUSP PROTAMINE ZINC PURIFIED BEEF
ChEMBL ID: CHEMBL1201541
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 1980

Molecule: INSULIN ZINC SUSP PROMPT PURIFIED PORK
ChEMBL ID: CHEMBL1201643
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 1982

Molecule: INSULIN SUSP ISOPHANE SEMISYNTHETIC PURIFIED HUMAN
ChEMBL ID: CHEMBL1201627
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 1985

Molecule: INSULIN ZINC SUSP PURIFIED BEEF
ChEMBL ID: CHEMBL1201546
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 1980

Molecule: INSULIN ZINC SUSP EXTENDED RECOMBINANT HUMAN
ChEMBL ID: CHEMBL1201641
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 1987

Molecule: INSULIN ASPART
ChEMBL ID: CHEMBL1201496
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 2000

Molecule: INSULIN ASPART PROTAMINE RECOMBINANT
ChEMBL ID: CHEMBL1201664
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 2001

Molecule: INSULIN DETEMIR
ChEMBL ID: CHEMBL2104391
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 2004

Molecule: INSULIN DEGLUDEC
ChEMBL ID: CHEMBL2107869
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 2013

Molecule: BMS-754807
ChEMBL ID: CHEMBL575448
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: KW-2450
ChEMBL ID: CHEMBL5283463
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: LINSITINIB
ChEMBL ID: CHEMBL1091644
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: INSULIN PEGLISPRO
ChEMBL ID: CHEMBL2108569
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Protein

Molecule: INSULIN ZINC, PROMPT
ChEMBL ID: CHEMBL2108493
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein

Molecule: INSULIN [INJECTION], BIPHASIC
ChEMBL ID: CHEMBL2108968
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein

Molecule: INSULIN TREGOPIL
ChEMBL ID: CHEMBL2108305
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Protein

Molecule: INSULIN, ISOPHANE
ChEMBL ID: CHEMBL2108964
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein

Molecule: INSULIN, PROTAMINE ZINC
ChEMBL ID: CHEMBL2109046
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein

Molecule: INSULIN HUMAN, ISOPHANE
ChEMBL ID: CHEMBL2108973
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Protein

Molecule: INSULIN ZINC, EXTENDED
ChEMBL ID: CHEMBL2108492
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL210):

Molecule: VILANTEROL TRIFENATATE
ChEMBL ID: CHEMBL1084172
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2013

Molecule: ALBUTEROL
ChEMBL ID: CHEMBL714
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1981

Molecule: PIRBUTEROL ACETATE
ChEMBL ID: CHEMBL1200444
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1986

Molecule: PROTOKYLOL HYDROCHLORIDE
ChEMBL ID: CHEMBL1200893
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1982

Molecule: LEVALBUTEROL HYDROCHLORIDE
ChEMBL ID: CHEMBL1201061
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1999

Molecule: ARFORMOTEROL TARTRATE
ChEMBL ID: CHEMBL1951071
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2006

Molecule: BITOLTEROL MESYLATE
ChEMBL ID: CHEMBL1200405
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1984

Molecule: SALMETEROL XINAFOATE
ChEMBL ID: CHEMBL1082607
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1994

Molecule: RITODRINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1367605
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1991

Molecule: INDACATEROL MALEATE
ChEMBL ID: CHEMBL1789842
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2009

Molecule: TERBUTALINE SULFATE
ChEMBL ID: CHEMBL1315867
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1974

Molecule: LEVALBUTEROL TARTRATE
ChEMBL ID: CHEMBL3989693
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2005

Molecule: FORMOTEROL FUMARATE
ChEMBL ID: CHEMBL3989798
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2001

Molecule: METAPROTERENOL SULFATE
ChEMBL ID: CHEMBL1568057
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1973

Molecule: ALBUTEROL SULFATE
ChEMBL ID: CHEMBL1441059
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1982

Molecule: ISOETHARINE MESYLATE
ChEMBL ID: CHEMBL1201153
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1984

Molecule: METIPRANOLOL HYDROCHLORIDE
ChEMBL ID: CHEMBL1200947
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1989

Molecule: NADOLOL
ChEMBL ID: CHEMBL521606
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1979

Molecule: NEBIVOLOL HYDROCHLORIDE
ChEMBL ID: CHEMBL1201731
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2007

Molecule: OXPRENOLOL HYDROCHLORIDE
ChEMBL ID: CHEMBL1200745
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1983

Molecule: PENBUTOLOL SULFATE
ChEMBL ID: CHEMBL2361370
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1987

Molecule: PROPAFENONE HYDROCHLORIDE
ChEMBL ID: CHEMBL1201063
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1989

Molecule: PROPRANOLOL HYDROCHLORIDE
ChEMBL ID: CHEMBL1671
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1967

Molecule: PINDOLOL
ChEMBL ID: CHEMBL500
Mechanism of Action: PARTIAL AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1982

Molecule: SOTALOL HYDROCHLORIDE
ChEMBL ID: CHEMBL1700
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1992

Molecule: ISOETHARINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1200920
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1979

Molecule: LEVOBUNOLOL HYDROCHLORIDE
ChEMBL ID: CHEMBL1201177
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1985

Molecule: TIMOLOL MALEATE
ChEMBL ID: CHEMBL1200870
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1978

Molecule: TIMOLOL
ChEMBL ID: CHEMBL499
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1978

Molecule: DOBUTAMINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1200418
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1978

Molecule: ESMOLOL HYDROCHLORIDE
ChEMBL ID: CHEMBL1201115
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1986

Molecule: OLODATEROL HYDROCHLORIDE
ChEMBL ID: CHEMBL2105743
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2014

Molecule: GSK159802
ChEMBL ID: CHEMBL3545087
Mechanism of Action: AGONIST
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: LAS190792
ChEMBL ID: CHEMBL3916700
Mechanism of Action: AGONIST
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: MILVETEROL
ChEMBL ID: CHEMBL1940832
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: LY377604
ChEMBL ID: CHEMBL2012520
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: BATEFENTEROL
ChEMBL ID: CHEMBL3039518
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: ABEDITEROL
ChEMBL ID: CHEMBL3039530
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: AZD3199
ChEMBL ID: CHEMBL3545103
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: BEDORADRINE SULFATE
ChEMBL ID: CHEMBL2218893
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: CARMOTEROL
ChEMBL ID: CHEMBL1094785
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: FENOTEROL
ChEMBL ID: CHEMBL32800
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: CELIPROLOL
ChEMBL ID: CHEMBL27810
Mechanism of Action: PARTIAL AGONIST
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: CLENBUTEROL
ChEMBL ID: CHEMBL49080
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: DILEVALOL HYDROCHLORIDE
ChEMBL ID: CHEMBL1204165
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1990

Molecule: ISOXSUPRINE HYDROCHLORIDE
ChEMBL ID: CHEMBL559180
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: PRONETALOL
ChEMBL ID: CHEMBL16476
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: BAMBUTEROL
ChEMBL ID: CHEMBL521589
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: NAVAFENTEROL
ChEMBL ID: CHEMBL4297483
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: PF-00610355
ChEMBL ID: CHEMBL1240967
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: PROCATEROL
ChEMBL ID: CHEMBL160519
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: TULOBUTEROL
ChEMBL ID: CHEMBL1159717
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: RIMITEROL
ChEMBL ID: CHEMBL88055
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: BUCINDOLOL HYDROCHLORIDE
ChEMBL ID: CHEMBL2107546
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: VILANTEROL .ALPHA.-PHENYL CINNAMATE
ChEMBL ID: CHEMBL1084173
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: REPROTEROL
ChEMBL ID: CHEMBL1095607
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL213):

Molecule: ATENOLOL
ChEMBL ID: CHEMBL24
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1981

Molecule: LEVOBETAXOLOL HYDROCHLORIDE
ChEMBL ID: CHEMBL1200837
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2000

Molecule: ACEBUTOLOL HYDROCHLORIDE
ChEMBL ID: CHEMBL1200813
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1984

Molecule: ESMOLOL HYDROCHLORIDE
ChEMBL ID: CHEMBL1201115
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1986

Molecule: OXPRENOLOL HYDROCHLORIDE
ChEMBL ID: CHEMBL1200745
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1983

Molecule: BISOPROLOL FUMARATE
ChEMBL ID: CHEMBL1472989
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1992

Molecule: LEVOBUNOLOL HYDROCHLORIDE
ChEMBL ID: CHEMBL1201177
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1985

Molecule: PINDOLOL
ChEMBL ID: CHEMBL500
Mechanism of Action: PARTIAL AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1982

Molecule: METIPRANOLOL HYDROCHLORIDE
ChEMBL ID: CHEMBL1200947
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1989

Molecule: DOBUTAMINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1200418
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1978

Molecule: DOPAMINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1557
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1974

Molecule: NADOLOL
ChEMBL ID: CHEMBL521606
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1979

Molecule: PROPRANOLOL HYDROCHLORIDE
ChEMBL ID: CHEMBL1671
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1967

Molecule: PENBUTOLOL SULFATE
ChEMBL ID: CHEMBL2361370
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1987

Molecule: SOTALOL HYDROCHLORIDE
ChEMBL ID: CHEMBL1700
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1992

Molecule: METOPROLOL FUMARATE
ChEMBL ID: CHEMBL3989566
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1989

Molecule: BETAXOLOL HYDROCHLORIDE
ChEMBL ID: CHEMBL1691
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1985

Molecule: TIMOLOL MALEATE
ChEMBL ID: CHEMBL1200870
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1978

Molecule: METOPROLOL SUCCINATE
ChEMBL ID: CHEMBL2356097
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1992

Molecule: METOPROLOL TARTRATE
ChEMBL ID: CHEMBL2062335
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1978

Molecule: NEBIVOLOL HYDROCHLORIDE
ChEMBL ID: CHEMBL1201731
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2007

Molecule: PROPAFENONE HYDROCHLORIDE
ChEMBL ID: CHEMBL1201063
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1989

Molecule: TIMOLOL
ChEMBL ID: CHEMBL499
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1978

Molecule: LY377604
ChEMBL ID: CHEMBL2012520
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: PRONETALOL
ChEMBL ID: CHEMBL16476
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: CELIPROLOL
ChEMBL ID: CHEMBL27810
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: LANDIOLOL
ChEMBL ID: CHEMBL1742466
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: XAMOTEROL
ChEMBL ID: CHEMBL75753
Mechanism of Action: PARTIAL AGONIST
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: PRACTOLOL
ChEMBL ID: CHEMBL6995
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: BUCINDOLOL HYDROCHLORIDE
ChEMBL ID: CHEMBL2107546
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL1780):

Molecule: CLOTRIMAZOLE
ChEMBL ID: CHEMBL104
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1975

Molecule: ECONAZOLE NITRATE
ChEMBL ID: CHEMBL1201049
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1982

Molecule: VORICONAZOLE
ChEMBL ID: CHEMBL638
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2002

Molecule: KETOCONAZOLE
ChEMBL ID: CHEMBL157101
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1981

Molecule: MICONAZOLE
ChEMBL ID: CHEMBL91
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1974

Molecule: ITRACONAZOLE
ChEMBL ID: CHEMBL64391
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1992

Molecule: TERCONAZOLE
ChEMBL ID: CHEMBL1306
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1987

Molecule: MICONAZOLE NITRATE
ChEMBL ID: CHEMBL1559
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1974

Molecule: FLUCONAZOLE
ChEMBL ID: CHEMBL106
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1990

Molecule: SULCONAZOLE NITRATE
ChEMBL ID: CHEMBL1200348
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1985

Molecule: TIOCONAZOLE
ChEMBL ID: CHEMBL1200438
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1983

Molecule: POSACONAZOLE
ChEMBL ID: CHEMBL1397
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2005

Molecule: SERTACONAZOLE NITRATE
ChEMBL ID: CHEMBL1200725
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2003

Molecule: BUTOCONAZOLE NITRATE
ChEMBL ID: CHEMBL1200398
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1985

Molecule: OXICONAZOLE NITRATE
ChEMBL ID: CHEMBL1200836
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1988

Molecule: LULICONAZOLE
ChEMBL ID: CHEMBL2105689
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2013

Molecule: RAVUCONAZOLE
ChEMBL ID: CHEMBL294029
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: FOSRAVUCONAZOLE
ChEMBL ID: CHEMBL333325
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL1983):

Molecule: DIHYDROERGOTAMINE MESYLATE
ChEMBL ID: CHEMBL1200517
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1946

Molecule: ERGOTAMINE TARTRATE
ChEMBL ID: CHEMBL2448612
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1948

Molecule: ELETRIPTAN HYDROBROMIDE
ChEMBL ID: CHEMBL1201003
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2002

Molecule: NARATRIPTAN HYDROCHLORIDE
ChEMBL ID: CHEMBL1200601
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1998

Molecule: ZOLMITRIPTAN
ChEMBL ID: CHEMBL1185
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1997

Molecule: ALMOTRIPTAN MALATE
ChEMBL ID: CHEMBL1200521
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2001

Molecule: FROVATRIPTAN SUCCINATE
ChEMBL ID: CHEMBL2138684
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2001

Molecule: RIZATRIPTAN BENZOATE
ChEMBL ID: CHEMBL1201032
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1998

Molecule: SUMATRIPTAN SUCCINATE
ChEMBL ID: CHEMBL1201150
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1992

Molecule: SUMATRIPTAN
ChEMBL ID: CHEMBL128
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1992

Molecule: GSK163090
ChEMBL ID: CHEMBL1631540
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: ELZASONAN HYDROCHLORIDE
ChEMBL ID: CHEMBL3989805
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: DONITRIPTAN
ChEMBL ID: CHEMBL1742428
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: FENFLURAMINE HYDROCHLORIDE
ChEMBL ID: CHEMBL2106217
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2020
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL235):

Molecule: PIOGLITAZONE HYDROCHLORIDE
ChEMBL ID: CHEMBL1715
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1999

Molecule: ROSIGLITAZONE MALEATE
ChEMBL ID: CHEMBL843
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1999

Molecule: TROGLITAZONE
ChEMBL ID: CHEMBL408
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1997

Molecule: BALSALAZIDE DISODIUM
ChEMBL ID: CHEMBL1200760
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2000

Molecule: MESALAMINE
ChEMBL ID: CHEMBL704
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1987

Molecule: OLSALAZINE SODIUM
ChEMBL ID: CHEMBL1201013
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1990

Molecule: AVE0847
ChEMBL ID: CHEMBL3545295
Mechanism of Action: AGONIST
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: DB959
ChEMBL ID: CHEMBL3545176
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: CLX-0921
ChEMBL ID: CHEMBL5314405
Mechanism of Action: AGONIST
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: NETOGLITAZONE
ChEMBL ID: CHEMBL93747
Mechanism of Action: MODULATOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: FARGLITAZAR
ChEMBL ID: CHEMBL107367
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: NAVEGLITAZAR
ChEMBL ID: CHEMBL181954
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: OMS405
ChEMBL ID: CHEMBL5095027
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: MK-0533
ChEMBL ID: CHEMBL490029
Mechanism of Action: MODULATOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: MBX-2044
ChEMBL ID: CHEMBL3545020
Mechanism of Action: MODULATOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: INT131
ChEMBL ID: CHEMBL1236924
Mechanism of Action: MODULATOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: ATX08-001
ChEMBL ID: CHEMBL3545278
Mechanism of Action: MODULATOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: EFATUTAZONE HYDROCHLORIDE
ChEMBL ID: CHEMBL3545279
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: ARHALOFENATE
ChEMBL ID: CHEMBL2103824
Mechanism of Action: MODULATOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: ETALOCIB
ChEMBL ID: CHEMBL329123
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: IMIGLITAZAR
ChEMBL ID: CHEMBL592054
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: ALEGLITAZAR
ChEMBL ID: CHEMBL519504
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: MURAGLITAZAR
ChEMBL ID: CHEMBL186179
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: TESAGLITAZAR
ChEMBL ID: CHEMBL282686
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: BALAGLITAZONE
ChEMBL ID: CHEMBL2103991
Mechanism of Action: PARTIAL AGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: RIVOGLITAZONE
ChEMBL ID: CHEMBL2104753
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: BARDOXOLONE METHYL
ChEMBL ID: CHEMBL1762621
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: MK-0767
ChEMBL ID: CHEMBL4297404
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: SAROGLITAZAR
ChEMBL ID: CHEMBL4297530
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: LERIGLITAZONE
ChEMBL ID: CHEMBL1267
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL1919):

Molecule: MIROGABALIN BESYLATE
ChEMBL ID: CHEMBL3545257
Mechanism of Action: MODULATOR
Max Phase: -1.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL246):

Molecule: MIRABEGRON
ChEMBL ID: CHEMBL2095212
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2012

Molecule: LY377604
ChEMBL ID: CHEMBL2012520
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: SOLABEGRON
ChEMBL ID: CHEMBL208427
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: VIBEGRON
ChEMBL ID: CHEMBL2107826
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2018

Molecule: RAFABEGRON
ChEMBL ID: CHEMBL279260
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: AMIBEGRON HYDROCHLORIDE
ChEMBL ID: CHEMBL545437
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: RITOBEGRON
ChEMBL ID: CHEMBL2107773
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL4068):

Molecule: FULACIMSTAT
ChEMBL ID: CHEMBL4297596
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL260):

Molecule: AMG-548
ChEMBL ID: CHEMBL585902
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: PEXMETINIB
ChEMBL ID: CHEMBL3991932
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: AVE-9940
ChEMBL ID: CHEMBL3545117
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: AZD-6703
ChEMBL ID: CHEMBL2031465
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: AZD-7624
ChEMBL ID: CHEMBL9960
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: DORAMAPIMOD
ChEMBL ID: CHEMBL103667
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: GSK-610677
ChEMBL ID: CHEMBL3544968
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: LEO-15520
ChEMBL ID: CHEMBL3545074
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: LY-3007113
ChEMBL ID: CHEMBL3544998
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: PF-03715455
ChEMBL ID: CHEMBL1938400
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: PS-516895
ChEMBL ID: CHEMBL3545139
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: R-1487
ChEMBL ID: CHEMBL1766582
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: RO-3201195
ChEMBL ID: CHEMBL203567
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: RWJ-67657
ChEMBL ID: CHEMBL190333
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: SB-85635
ChEMBL ID: CHEMBL3545384
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: SC-80036
ChEMBL ID: CHEMBL3544930
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: SCIO-323
ChEMBL ID: CHEMBL1614702
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: SD-0006
ChEMBL ID: CHEMBL1090173
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: TA-5493
ChEMBL ID: CHEMBL3545201
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: ARRY-797
ChEMBL ID: CHEMBL1088750
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: BMS-582949
ChEMBL ID: CHEMBL1230065
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: SEMAPIMOD
ChEMBL ID: CHEMBL2107779
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: FX-005
ChEMBL ID: CHEMBL3545216
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: DILMAPIMOD
ChEMBL ID: CHEMBL2103838
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: ITX-5061
ChEMBL ID: CHEMBL3402567
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: RALIMETINIB
ChEMBL ID: CHEMBL2364626
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: PG-760564
ChEMBL ID: CHEMBL3545398
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: PH-797804
ChEMBL ID: CHEMBL1088751
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: PAMAPIMOD
ChEMBL ID: CHEMBL1090089
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: TALMAPIMOD
ChEMBL ID: CHEMBL514201
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: TAK-715
ChEMBL ID: CHEMBL363648
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: VX-702
ChEMBL ID: CHEMBL1090090
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: NEFLAMAPIMOD
ChEMBL ID: CHEMBL119385
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: ACUMAPIMOD
ChEMBL ID: CHEMBL5314397
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: LOSMAPIMOD
ChEMBL ID: CHEMBL1088752
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL4929):

Molecule: DEZAMIZUMAB
ChEMBL ID: CHEMBL4297966
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: MIRIDESAP
ChEMBL ID: CHEMBL25263
Mechanism of Action: CROSS-LINKING AGENT
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3706):

Molecule: APRATASTAT
ChEMBL ID: CHEMBL206815
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL4501):

Molecule: LY-2584702
ChEMBL ID: CHEMBL3545076
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL5167):

Molecule: AFACIFENACIN
ChEMBL ID: CHEMBL3545165
Mechanism of Action: BLOCKER
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL4683):

Molecule: F19 131I
ChEMBL ID: CHEMBL2109643
Mechanism of Action: BINDING AGENT
Max Phase: 3.0
Molecule Type: Antibody

Molecule: SIBROTUZUMAB
ChEMBL ID: CHEMBL2108882
Mechanism of Action: BINDING AGENT
Max Phase: 2.0
Molecule Type: Antibody

Molecule: SIMLUKAFUSP ALFA
ChEMBL ID: CHEMBL4298090
Mechanism of Action: BINDING AGENT
Max Phase: 2.0
Molecule Type: Protein
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL5398):

Molecule: ALVERINE
ChEMBL ID: CHEMBL253371
Mechanism of Action: ACTIVATOR
Max Phase: 4.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL1744522):

Molecule: BELZUTIFAN
ChEMBL ID: CHEMBL4585668
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2021
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL1795122):

Molecule: PLITIDEPSIN
ChEMBL ID: CHEMBL451930
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL1907589):

Molecule: NICOTINE POLACRILEX
ChEMBL ID: CHEMBL1201536
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1984

Molecule: NICOTINE
ChEMBL ID: CHEMBL3
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1984

Molecule: VARENICLINE TARTRATE
ChEMBL ID: CHEMBL5303393
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2006

Molecule: TC-2216
ChEMBL ID: CHEMBL504652
Mechanism of Action: ANTAGONIST
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: ABT-560
ChEMBL ID: CHEMBL3707354
Mechanism of Action: MODULATOR
Max Phase: -1.0
Molecule Type: Small molecule

Molecule: ISPRONICLINE
ChEMBL ID: CHEMBL188462
Mechanism of Action: PARTIAL AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: TEBANICLINE TOSYLATE
ChEMBL ID: CHEMBL2104964
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: SOFINICLINE
ChEMBL ID: CHEMBL238465
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: SIMPINICLINE
ChEMBL ID: CHEMBL4594254
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: AZD1446
ChEMBL ID: CHEMBL2179529
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: CP-601927
ChEMBL ID: CHEMBL3707250
Mechanism of Action: PARTIAL AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: ALTINICLINE
ChEMBL ID: CHEMBL111659
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: DEXMECAMYLAMINE
ChEMBL ID: CHEMBL2103881
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: CYTISINICLINE
ChEMBL ID: CHEMBL497939
Mechanism of Action: PARTIAL AGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: VARENICLINE
ChEMBL ID: CHEMBL1076903
Mechanism of Action: PARTIAL AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2006

Molecule: DIANICLINE
ChEMBL ID: CHEMBL187927
Mechanism of Action: PARTIAL AGONIST
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL1907594):

Molecule: MECAMYLAMINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1237082
Mechanism of Action: NEGATIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1956

Molecule: PENTOLINIUM TARTRATE
ChEMBL ID: CHEMBL1318287
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1982

Molecule: TRIMETHAPHAN CAMSYLATE
ChEMBL ID: CHEMBL1245
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1982

Molecule: SIMPINICLINE
ChEMBL ID: CHEMBL4594254
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: ASM-024
ChEMBL ID: CHEMBL3707249
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: LARAZOTIDE ACETATE
ChEMBL ID: CHEMBL2103815
Mechanism of Action: PARTIAL AGONIST
Max Phase: 3.0
Molecule Type: Protein
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL1907599):

Molecule: NATALIZUMAB
ChEMBL ID: CHEMBL1201607
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2004

Molecule: FIRATEGRAST
ChEMBL ID: CHEMBL2104967
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2093872):

Molecule: METHOXYFLURANE
ChEMBL ID: CHEMBL1341
Mechanism of Action: POSITIVE MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: FLUMAZENIL
ChEMBL ID: CHEMBL407
Mechanism of Action: ALLOSTERIC ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1991

Molecule: CLORAZEPATE DIPOTASSIUM
ChEMBL ID: CHEMBL2096631
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1972

Molecule: CHLORDIAZEPOXIDE
ChEMBL ID: CHEMBL451
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1960

Molecule: CHLORDIAZEPOXIDE HYDROCHLORIDE
ChEMBL ID: CHEMBL1200703
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1960

Molecule: DIAZEPAM
ChEMBL ID: CHEMBL12
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1963

Molecule: ESZOPICLONE
ChEMBL ID: CHEMBL1522
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2004

Molecule: OXAZEPAM
ChEMBL ID: CHEMBL568
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1965

Molecule: MEPROBAMATE
ChEMBL ID: CHEMBL979
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1955

Molecule: CLOBAZAM
ChEMBL ID: CHEMBL70418
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2005

Molecule: ALPRAZOLAM
ChEMBL ID: CHEMBL661
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1981

Molecule: TRIAZOLAM
ChEMBL ID: CHEMBL646
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1978

Molecule: BUTALBITAL
ChEMBL ID: CHEMBL454
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1983

Molecule: CLONAZEPAM
ChEMBL ID: CHEMBL452
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1975

Molecule: DESFLURANE
ChEMBL ID: CHEMBL1200733
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1992

Molecule: ESTAZOLAM
ChEMBL ID: CHEMBL285674
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1990

Molecule: TALBUTAL
ChEMBL ID: CHEMBL1200802
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1982

Molecule: BUTABARBITAL SODIUM
ChEMBL ID: CHEMBL1200982
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1939

Molecule: GLUTETHIMIDE
ChEMBL ID: CHEMBL1102
Mechanism of Action: POSITIVE MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1976

Molecule: ACAMPROSATE CALCIUM
ChEMBL ID: CHEMBL2068724
Mechanism of Action: POSITIVE MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2004

Molecule: LORAZEPAM
ChEMBL ID: CHEMBL580
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1977

Molecule: ENFLURANE
ChEMBL ID: CHEMBL1257
Mechanism of Action: POSITIVE MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1972

Molecule: ETHCHLORVYNOL
ChEMBL ID: CHEMBL591
Mechanism of Action: POSITIVE MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1961

Molecule: METHARBITAL
ChEMBL ID: CHEMBL450
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1982

Molecule: METHOHEXITAL SODIUM
ChEMBL ID: CHEMBL30219
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1960

Molecule: METHYPRYLON
ChEMBL ID: CHEMBL1200790
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1982

Molecule: MIDAZOLAM HYDROCHLORIDE
ChEMBL ID: CHEMBL1200420
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1985

Molecule: PRAZEPAM
ChEMBL ID: CHEMBL969
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1982

Molecule: PRIMIDONE
ChEMBL ID: CHEMBL856
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1954

Molecule: PROPOFOL
ChEMBL ID: CHEMBL526
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1989

Molecule: QUAZEPAM
ChEMBL ID: CHEMBL1200472
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1985

Molecule: PENTOBARBITAL
ChEMBL ID: CHEMBL448
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1973

Molecule: PENTOBARBITAL SODIUM
ChEMBL ID: CHEMBL971
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1973

Molecule: SECOBARBITAL SODIUM
ChEMBL ID: CHEMBL1200903
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1950

Molecule: SEVOFLURANE
ChEMBL ID: CHEMBL1200694
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1995

Molecule: TEMAZEPAM
ChEMBL ID: CHEMBL967
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1981

Molecule: THIAMYLAL SODIUM
ChEMBL ID: CHEMBL1201065
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1982

Molecule: THIOPENTAL SODIUM
ChEMBL ID: CHEMBL738
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1982

Molecule: ETOMIDATE
ChEMBL ID: CHEMBL681
Mechanism of Action: POSITIVE MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1982

Molecule: FLURAZEPAM HYDROCHLORIDE
ChEMBL ID: CHEMBL3989724
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1970

Molecule: HALAZEPAM
ChEMBL ID: CHEMBL970
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1981

Molecule: HALOTHANE
ChEMBL ID: CHEMBL931
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1958

Molecule: ISOFLURANE
ChEMBL ID: CHEMBL1256
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1979

Molecule: TOPIRAMATE
ChEMBL ID: CHEMBL220492
Mechanism of Action: POSITIVE MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1996

Molecule: TRICLOFOS SODIUM
ChEMBL ID: CHEMBL1200789
Mechanism of Action: POSITIVE MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1982

Molecule: ADIPIPLON
ChEMBL ID: CHEMBL2103791
Mechanism of Action: PARTIAL AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: LOREDIPLON
ChEMBL ID: CHEMBL3707317
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: RESEQUINIL
ChEMBL ID: CHEMBL2107801
Mechanism of Action: INVERSE AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: DARIGABAT
ChEMBL ID: CHEMBL3647536
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: GANAXOLONE
ChEMBL ID: CHEMBL1568698
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2022

Molecule: PAGOCLONE
ChEMBL ID: CHEMBL2104745
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: FLUNITRAZEPAM
ChEMBL ID: CHEMBL13280
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: METHAQUALONE
ChEMBL ID: CHEMBL282052
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: METHAQUALONE HYDROCHLORIDE
ChEMBL ID: CHEMBL2106829
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: TETRAZEPAM
ChEMBL ID: CHEMBL2105527
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: CLOMETHIAZOLE
ChEMBL ID: CHEMBL315795
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: CLOTIAZEPAM
ChEMBL ID: CHEMBL1697737
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: MIDAZOLAM
ChEMBL ID: CHEMBL655
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1985

Molecule: BREXANOLONE
ChEMBL ID: CHEMBL207538
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2019

Molecule: CENOBAMATE
ChEMBL ID: CHEMBL3989949
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2020

Molecule: ETIFOXINE
ChEMBL ID: CHEMBL2106227
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: REMIMAZOLAM BESYLATE
ChEMBL ID: CHEMBL4594301
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2020

Molecule: ABP-700
ChEMBL ID: CHEMBL4297255
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: CIPEPOFOL
ChEMBL ID: CHEMBL4094894
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: PADSEVONIL
ChEMBL ID: CHEMBL4297521
Mechanism of Action: PARTIAL AGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: ZURANOLONE
ChEMBL ID: CHEMBL4105630
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2023
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2094138):

Molecule: GSK-690693
ChEMBL ID: CHEMBL494089
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2094255):

Molecule: ETOPOSIDE
ChEMBL ID: CHEMBL44657
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1983

Molecule: TENIPOSIDE
ChEMBL ID: CHEMBL452231
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1992

Molecule: C-1311
ChEMBL ID: CHEMBL3545337
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: BERUBICIN HYDROCHLORIDE
ChEMBL ID: CHEMBL2103796
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: VOSAROXIN
ChEMBL ID: CHEMBL68117
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: BECATECARIN
ChEMBL ID: CHEMBL2107313
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: AMSACRINE
ChEMBL ID: CHEMBL43
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1987

Molecule: PAZUFLOXACIN
ChEMBL ID: CHEMBL240163
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: DEXRAZOXANE
ChEMBL ID: CHEMBL1738
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1995

Molecule: DEXRAZOXANE HYDROCHLORIDE
ChEMBL ID: CHEMBL1200778
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1995
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2095173):

Molecule: OMEPRAZOLE
ChEMBL ID: CHEMBL1503
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1989

Molecule: DEXLANSOPRAZOLE
ChEMBL ID: CHEMBL1201863
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2009

Molecule: OMEPRAZOLE MAGNESIUM
ChEMBL ID: CHEMBL1567328
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2003

Molecule: RABEPRAZOLE SODIUM
ChEMBL ID: CHEMBL1200930
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1999

Molecule: PANTOPRAZOLE SODIUM
ChEMBL ID: CHEMBL3989559
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2000

Molecule: LANSOPRAZOLE
ChEMBL ID: CHEMBL480
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1995

Molecule: ESOMEPRAZOLE SODIUM
ChEMBL ID: CHEMBL1200470
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2005

Molecule: ESOMEPRAZOLE MAGNESIUM
ChEMBL ID: CHEMBL5314366
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2001

Molecule: ESOMEPRAZOLE STRONTIUM
ChEMBL ID: CHEMBL2146140
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2013

Molecule: VONOPRAZAN FUMARATE
ChEMBL ID: CHEMBL2064032
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2022

Molecule: TEGOPRAZAN
ChEMBL ID: CHEMBL4297583
Mechanism of Action: BLOCKER
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: ILAPRAZOLE
ChEMBL ID: CHEMBL2106370
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: ABEPRAZAN
ChEMBL ID: CHEMBL4594445
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2095188):

Molecule: LITHIUM CARBONATE
ChEMBL ID: CHEMBL1200826
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1970

Molecule: LITHIUM CITRATE
ChEMBL ID: CHEMBL2103738
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1980

Molecule: AZD-1080
ChEMBL ID: CHEMBL1969664
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2107836):

Molecule: TRIAMTERENE
ChEMBL ID: CHEMBL585
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1964

Molecule: AMILORIDE HYDROCHLORIDE
ChEMBL ID: CHEMBL1398126
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1981

Molecule: IDREVLORIDE
ChEMBL ID: CHEMBL5095031
Mechanism of Action: BLOCKER
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2109237):

Molecule: POZANICLINE
ChEMBL ID: CHEMBL127071
Mechanism of Action: PARTIAL AGONIST
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2111348):

Molecule: NITROGLYCERIN
ChEMBL ID: CHEMBL730
Mechanism of Action: ACTIVATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1981

Molecule: NITRIC OXIDE
ChEMBL ID: CHEMBL1200689
Mechanism of Action: ACTIVATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1999

Molecule: SODIUM NITROPRUSSIDE
ChEMBL ID: CHEMBL136478
Mechanism of Action: ACTIVATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1981

Molecule: ISOSORBIDE MONONITRATE
ChEMBL ID: CHEMBL1311
Mechanism of Action: ACTIVATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1991

Molecule: ISOSORBIDE DINITRATE
ChEMBL ID: CHEMBL6622
Mechanism of Action: ACTIVATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1986

Molecule: RIOCIGUAT
ChEMBL ID: CHEMBL2107834
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2013

Molecule: CINACIGUAT
ChEMBL ID: CHEMBL1236936
Mechanism of Action: ACTIVATOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: PRALICIGUAT
ChEMBL ID: CHEMBL4297214
Mechanism of Action: ACTIVATOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: OLINCIGUAT
ChEMBL ID: CHEMBL4297616
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: VERICIGUAT
ChEMBL ID: CHEMBL4066936
Mechanism of Action: ACTIVATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2021

Molecule: PENTAERYTHRITOL TETRANITRATE
ChEMBL ID: CHEMBL466659
Mechanism of Action: ACTIVATOR
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: ATACIGUAT
ChEMBL ID: CHEMBL2107729
Mechanism of Action: ACTIVATOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: RUNCACIGUAT
ChEMBL ID: CHEMBL4650322
Mechanism of Action: ACTIVATOR
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2111392):

Molecule: ZOLPIDEM TARTRATE
ChEMBL ID: CHEMBL3989820
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1992

Molecule: ZALEPLON
ChEMBL ID: CHEMBL1521
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1999
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2111353):

Molecule: MIRANSERTIB
ChEMBL ID: CHEMBL4297188
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: GSK-690693
ChEMBL ID: CHEMBL494089
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: LY-2780301
ChEMBL ID: CHEMBL3545134
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: MK-2201
ChEMBL ID: CHEMBL3545000
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: XL-418
ChEMBL ID: CHEMBL2016893
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: AFURESERTIB
ChEMBL ID: CHEMBL2219422
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: UPROSERTIB
ChEMBL ID: CHEMBL3137336
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: MK-2206
ChEMBL ID: CHEMBL1079175
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: IPATASERTIB
ChEMBL ID: CHEMBL2177390
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: TRICIRIBINE PHOSPHATE
ChEMBL ID: CHEMBL462018
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: CAPIVASERTIB
ChEMBL ID: CHEMBL2325741
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2023

Molecule: PIFUSERTIB
ChEMBL ID: CHEMBL4297329
Mechanism of Action: NEGATIVE ALLOSTERIC MODULATOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: TAS0612
ChEMBL ID: CHEMBL4650277
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2111362):

Molecule: ROVELIZUMAB
ChEMBL ID: CHEMBL2109224
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Antibody
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2331065):

Molecule: BISANTRENE
ChEMBL ID: CHEMBL25336
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2363032):

Molecule: BEPRIDIL HYDROCHLORIDE
ChEMBL ID: CHEMBL1200382
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1990

Molecule: PREGABALIN
ChEMBL ID: CHEMBL1059
Mechanism of Action: MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2004

Molecule: GABAPENTIN
ChEMBL ID: CHEMBL940
Mechanism of Action: MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1993

Molecule: GABAPENTIN ENACARBIL
ChEMBL ID: CHEMBL1628502
Mechanism of Action: MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2011

Molecule: ATAGABALIN
ChEMBL ID: CHEMBL593430
Mechanism of Action: MODULATOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: IMAGABALIN
ChEMBL ID: CHEMBL2103836
Mechanism of Action: MODULATOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: SULOCTIDIL
ChEMBL ID: CHEMBL404849
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1979

Molecule: TERODILINE HYDROCHLORIDE
ChEMBL ID: CHEMBL539770
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1986

Molecule: PHLOROGLUCINOL
ChEMBL ID: CHEMBL473159
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2363042):

Molecule: CLOFARABINE
ChEMBL ID: CHEMBL1750
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2004

Molecule: CYTARABINE
ChEMBL ID: CHEMBL803
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1969

Molecule: FLUDARABINE PHOSPHATE
ChEMBL ID: CHEMBL1096882
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1991

Molecule: GEMCITABINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1637
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1996

Molecule: TROXACITABINE
ChEMBL ID: CHEMBL359164
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: ASPACYTARABINE
ChEMBL ID: CHEMBL4297599
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2363052):

Molecule: METHOXYFLURANE
ChEMBL ID: CHEMBL1341
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: DESFLURANE
ChEMBL ID: CHEMBL1200733
Mechanism of Action: POSITIVE MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1992

Molecule: ENFLURANE
ChEMBL ID: CHEMBL1257
Mechanism of Action: POSITIVE MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1972

Molecule: SEVOFLURANE
ChEMBL ID: CHEMBL1200694
Mechanism of Action: POSITIVE MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1995

Molecule: HALOTHANE
ChEMBL ID: CHEMBL931
Mechanism of Action: POSITIVE MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1958

Molecule: ISOFLURANE
ChEMBL ID: CHEMBL1256
Mechanism of Action: POSITIVE MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1979
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2363068):

Molecule: DINOPROSTONE
ChEMBL ID: CHEMBL548
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1977
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2363070):

Molecule: BEXAROTENE
ChEMBL ID: CHEMBL1023
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1999

Molecule: IRX-4204
ChEMBL ID: CHEMBL75133
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2363071):

Molecule: ALITRETINOIN
ChEMBL ID: CHEMBL705
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1999

Molecule: ACITRETIN
ChEMBL ID: CHEMBL1131
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1996

Molecule: ETRETINATE
ChEMBL ID: CHEMBL464
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1986

Molecule: MOFAROTENE
ChEMBL ID: CHEMBL146506
Mechanism of Action: MODULATOR
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2363852):

Molecule: FIDAXOMICIN
ChEMBL ID: CHEMBL1255800
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2011
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2364172):

Molecule: EFALIZUMAB
ChEMBL ID: CHEMBL1201575
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2003

Molecule: LIFITEGRAST
ChEMBL ID: CHEMBL2048028
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2016

Molecule: ROVELIZUMAB
ChEMBL ID: CHEMBL2109224
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Antibody
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2364672):

Molecule: RIFAMPIN
ChEMBL ID: CHEMBL374478
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1971

Molecule: RIFABUTIN
ChEMBL ID: CHEMBL444633
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1992

Molecule: RIFAPENTINE
ChEMBL ID: CHEMBL1660
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1998

Molecule: RIFAXIMIN
ChEMBL ID: CHEMBL1617
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2004

Molecule: RIFAQUIZINONE
ChEMBL ID: CHEMBL4594404
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2364683):

Molecule: ACETOHYDROXAMIC ACID
ChEMBL ID: CHEMBL734
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1983
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2364709):

Molecule: FIBRINOLYSIN, HUMAN
ChEMBL ID: CHEMBL1201505
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Unknown
First Approval: 1964

Molecule: ALFIMEPRASE
ChEMBL ID: CHEMBL2108893
Mechanism of Action: HYDROLYTIC ENZYME
Max Phase: 3.0
Molecule Type: Enzyme

Molecule: FIBRINOGEN, HUMAN
ChEMBL ID: CHEMBL2109072
Mechanism of Action: EXOGENOUS PROTEIN
Max Phase: 3.0
Molecule Type: Unknown

Molecule: ANCROD
ChEMBL ID: CHEMBL2108481
Mechanism of Action: HYDROLYTIC ENZYME
Max Phase: 3.0
Molecule Type: Unknown

Molecule: PLASMINOGEN
ChEMBL ID: CHEMBL2108131
Mechanism of Action: HYDROLYTIC ENZYME
Max Phase: 3.0
Molecule Type: Unknown
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3307221):

Molecule: EFINACONAZOLE
ChEMBL ID: CHEMBL2103877
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2014
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3390824):

Molecule: ISAVUCONAZONIUM SULFATE
ChEMBL ID: CHEMBL3137333
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2015
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3559703):

Molecule: AZD-6482
ChEMBL ID: CHEMBL2165191
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: DS-7423
ChEMBL ID: CHEMBL3545248
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: GSK-1059615
ChEMBL ID: CHEMBL3544966
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: OMIPALISIB
ChEMBL ID: CHEMBL1236962
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: RECILISIB
ChEMBL ID: CHEMBL2219421
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: PANULISIB
ChEMBL ID: CHEMBL5095025
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: IZORLISIB
ChEMBL ID: CHEMBL1684984
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: PWT-33587
ChEMBL ID: CHEMBL3545006
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: PAXALISIB
ChEMBL ID: CHEMBL3813842
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: SF-1126
ChEMBL ID: CHEMBL2326966
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: VS-5584
ChEMBL ID: CHEMBL1079593
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: WX-037
ChEMBL ID: CHEMBL3545385
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: PUQUITINIB MESYLATE DIHYDRATE
ChEMBL ID: CHEMBL4596972
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: DACTOLISIB
ChEMBL ID: CHEMBL1879463
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: BGT-226
ChEMBL ID: CHEMBL3545096
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: BUPARLISIB
ChEMBL ID: CHEMBL2017974
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: PF-04691502
ChEMBL ID: CHEMBL1234354
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: GEDATOLISIB
ChEMBL ID: CHEMBL592445
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: SONOLISIB
ChEMBL ID: CHEMBL411907
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: PICTILISIB
ChEMBL ID: CHEMBL521851
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: APITOLISIB
ChEMBL ID: CHEMBL1922094
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: TASELISIB
ChEMBL ID: CHEMBL2387080
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: PILARALISIB
ChEMBL ID: CHEMBL3360203
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: VOXTALISIB
ChEMBL ID: CHEMBL3545366
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: ZSTK-474
ChEMBL ID: CHEMBL586702
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: SAMOTOLISIB
ChEMBL ID: CHEMBL4297181
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3580506):

Molecule: MEDI-500
ChEMBL ID: CHEMBL2109592
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Antibody

Molecule: TOL-101
ChEMBL ID: CHEMBL2109591
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: MASLIMOMAB
ChEMBL ID: CHEMBL2108474
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3706564):

Molecule: ABEQUOLIXRON
ChEMBL ID: CHEMBL573677
Mechanism of Action: AGONIST
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: ROVAZOLAC
ChEMBL ID: CHEMBL4297218
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3833421):

Molecule: BAMINERCEPT
ChEMBL ID: CHEMBL1742988
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Protein
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3885507):

Molecule: PF-05175157
ChEMBL ID: CHEMBL3359265
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: OLUMACOSTAT GLASARETIL
ChEMBL ID: CHEMBL3989947
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: FIRSOCOSTAT
ChEMBL ID: CHEMBL3407547
Mechanism of Action: NEGATIVE ALLOSTERIC MODULATOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: CLESACOSTAT
ChEMBL ID: CHEMBL4567446
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL4296169):

Molecule: RIFAMYCIN SODIUM
ChEMBL ID: CHEMBL2105680
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2018

Molecule: RIFALAZIL
ChEMBL ID: CHEMBL236297
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL4630724):

Molecule: TAS0612
ChEMBL ID: CHEMBL4650277
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL4662933):

Molecule: ALBACONAZOLE
ChEMBL ID: CHEMBL298817
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: BIFONAZOLE
ChEMBL ID: CHEMBL277535
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: OTESECONAZOLE
ChEMBL ID: CHEMBL3311228
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2022
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL4665592):

Molecule: RECOMBINANT HUMAN INTERLEUKIN-15
ChEMBL ID: CHEMBL4650421
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Unknown
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL1881):

Molecule: ALPROSTADIL
ChEMBL ID: CHEMBL495
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1981

Molecule: OMIDENEPAG
ChEMBL ID: CHEMBL3707245
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: OMIDENEPAG ISOPROPYL
ChEMBL ID: CHEMBL4297666
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2022

Molecule: TAPRENEPAG ISOPROPYL
ChEMBL ID: CHEMBL2105692
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: SIMENEPAG ISOPROPYL
ChEMBL ID: CHEMBL2105710
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: EVATANEPAG
ChEMBL ID: CHEMBL563646
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL1995):

Molecule: TREPROSTINIL
ChEMBL ID: CHEMBL1237119
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2002

Molecule: ILOPROST
ChEMBL ID: CHEMBL494
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2003

Molecule: EPOPROSTENOL SODIUM
ChEMBL ID: CHEMBL962
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1995

Molecule: TREPROSTINIL DIOLAMINE
ChEMBL ID: CHEMBL2107815
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2013

Molecule: SELEXIPAG
ChEMBL ID: CHEMBL238804
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2015

Molecule: RALINEPAG
ChEMBL ID: CHEMBL3301604
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: ESUBERAPROST
ChEMBL ID: CHEMBL3137314
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: TREPROSTINIL SODIUM
ChEMBL ID: CHEMBL561157
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2020

Molecule: ILOPROST TROMETHAMINE
ChEMBL ID: CHEMBL5315118
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2003
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL1959):

Molecule: ANAKINRA
ChEMBL ID: CHEMBL1201570
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 2001

Molecule: AMG-108
ChEMBL ID: CHEMBL2109458
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Antibody

Molecule: MEDI-8968
ChEMBL ID: CHEMBL2109607
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL1957):

Molecule: MECASERMIN RINFABATE
ChEMBL ID: CHEMBL1201717
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 2005

Molecule: MECASERMIN
ChEMBL ID: CHEMBL1201716
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 2005

Molecule: AEW-541
ChEMBL ID: CHEMBL551064
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: PL-225B
ChEMBL ID: CHEMBL3545004
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: XL-228
ChEMBL ID: CHEMBL3545085
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: AXL-1717
ChEMBL ID: CHEMBL283120
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: BMS-754807
ChEMBL ID: CHEMBL575448
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: MASOPROCOL
ChEMBL ID: CHEMBL313972
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1992

Molecule: KW-2450
ChEMBL ID: CHEMBL5283463
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: LINSITINIB
ChEMBL ID: CHEMBL1091644
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: FIGITUMUMAB
ChEMBL ID: CHEMBL1743019
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Antibody

Molecule: GANITUMAB
ChEMBL ID: CHEMBL1743024
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Antibody

Molecule: TEPROTUMUMAB
ChEMBL ID: CHEMBL1743079
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2020

Molecule: CIXUTUMUMAB
ChEMBL ID: CHEMBL1743001
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Antibody

Molecule: DALOTUZUMAB
ChEMBL ID: CHEMBL1743006
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Antibody

Molecule: ROBATUMUMAB
ChEMBL ID: CHEMBL1743064
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Antibody

Molecule: VELIGROTUG
ChEMBL ID: CHEMBL2109357
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Antibody

Molecule: BIIB-022
ChEMBL ID: CHEMBL2109356
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Antibody

Molecule: ISTIRATUMAB
ChEMBL ID: CHEMBL3989990
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: CONTELTINIB 
ChEMBL ID: CHEMBL3899477
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2069):

Molecule: TERUTROBAN
ChEMBL ID: CHEMBL2107786
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: TERBOGREL
ChEMBL ID: CHEMBL281398
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: SERATRODAST
ChEMBL ID: CHEMBL70972
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1995

Molecule: RAMATROBAN
ChEMBL ID: CHEMBL361812
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2000

Molecule: PICOTAMIDE
ChEMBL ID: CHEMBL1257015
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL1811):

Molecule: ALPROSTADIL
ChEMBL ID: CHEMBL495
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1981

Molecule: ONO-8539
ChEMBL ID: CHEMBL3912251
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL1836):

Molecule: RIVENPROST
ChEMBL ID: CHEMBL303960
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: VORBIPIPRANT
ChEMBL ID: CHEMBL3920982
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: GRAPIPRANT
ChEMBL ID: CHEMBL3039498
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule
First Approval: 2018
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3710):

Molecule: MISOPROSTOL
ChEMBL ID: CHEMBL606
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1988

Molecule: SEPETAPROST
ChEMBL ID: CHEMBL4297633
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2476):

Molecule: FLINDOKALNER
ChEMBL ID: CHEMBL266510
Mechanism of Action: ACTIVATOR
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2413):

Molecule: CCX354
ChEMBL ID: CHEMBL4444976
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: AZD4818
ChEMBL ID: CHEMBL2178570
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: BMS-817399
ChEMBL ID: CHEMBL3334824
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2487):

Molecule: GANTENERUMAB
ChEMBL ID: CHEMBL1743025
Mechanism of Action: BINDING AGENT
Max Phase: 3.0
Molecule Type: Antibody

Molecule: SOLANEZUMAB
ChEMBL ID: CHEMBL1743072
Mechanism of Action: BINDING AGENT
Max Phase: 3.0
Molecule Type: Antibody

Molecule: BAPINEUZUMAB
ChEMBL ID: CHEMBL2108576
Mechanism of Action: BINDING AGENT
Max Phase: 3.0
Molecule Type: Antibody

Molecule: ADUCANUMAB
ChEMBL ID: CHEMBL3039540
Mechanism of Action: BINDING AGENT
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2021

Molecule: CRENEZUMAB
ChEMBL ID: CHEMBL1743004
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody

Molecule: PONEZUMAB
ChEMBL ID: CHEMBL1743058
Mechanism of Action: BINDING AGENT
Max Phase: 2.0
Molecule Type: Antibody

Molecule: GSK933776
ChEMBL ID: CHEMBL2109300
Mechanism of Action: BINDING AGENT
Max Phase: 2.0
Molecule Type: Antibody

Molecule: LECANEMAB
ChEMBL ID: CHEMBL3833321
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2023

Molecule: TRAMIPROSATE
ChEMBL ID: CHEMBL149082
Mechanism of Action: STABILISER
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: DONANEMAB
ChEMBL ID: CHEMBL4297245
Mechanism of Action: DISRUPTING AGENT
Max Phase: 3.0
Molecule Type: Antibody

Molecule: VANUTIDE CRIDIFICAR
ChEMBL ID: CHEMBL2108058
Mechanism of Action: VACCINE ANTIGEN
Max Phase: 2.0
Molecule Type: Protein

Molecule: AMILOMOTIDE
ChEMBL ID: CHEMBL2108328
Mechanism of Action: VACCINE ANTIGEN
Max Phase: 2.0
Molecule Type: Protein

Molecule: VALILTRAMIPROSATE
ChEMBL ID: CHEMBL4650301
Mechanism of Action: STABILISER
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3576):

Molecule: FLINDOKALNER
ChEMBL ID: CHEMBL266510
Mechanism of Action: ACTIVATOR
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2689):

Molecule: MK-8033
ChEMBL ID: CHEMBL2323775
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: NARNATUMAB
ChEMBL ID: CHEMBL1743046
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: GLESATINIB
ChEMBL ID: CHEMBL3989914
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2925):

Molecule: FLINDOKALNER
ChEMBL ID: CHEMBL266510
Mechanism of Action: ACTIVATOR
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL4427):

Molecule: LAROPIPRANT
ChEMBL ID: CHEMBL426559
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: VIDUPIPRANT
ChEMBL ID: CHEMBL1951575
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: ASAPIPRANT
ChEMBL ID: CHEMBL3545043
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL5071):

Molecule: ARRY-502
ChEMBL ID: CHEMBL5314403
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: AM-211
ChEMBL ID: CHEMBL2181753
Mechanism of Action: ANTAGONIST
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: AM-461
ChEMBL ID: CHEMBL5095021
Mechanism of Action: ANTAGONIST
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: MK-7246
ChEMBL ID: CHEMBL561132
Mechanism of Action: ANTAGONIST
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: RG7185
ChEMBL ID: CHEMBL3544941
Mechanism of Action: ANTAGONIST
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: MK-1029
ChEMBL ID: CHEMBL3545031
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: ADC3680
ChEMBL ID: CHEMBL3545343
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: AZD1981
ChEMBL ID: CHEMBL1914489
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: FEVIPIPRANT
ChEMBL ID: CHEMBL3137332
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: QAV680
ChEMBL ID: CHEMBL2442750
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: TIMAPIPRANT
ChEMBL ID: CHEMBL560993
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: DONITRIPTAN
ChEMBL ID: CHEMBL1742428
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: VIDUPIPRANT
ChEMBL ID: CHEMBL1951575
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: SETIPIPRANT
ChEMBL ID: CHEMBL2386081
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: RAMATROBAN
ChEMBL ID: CHEMBL361812
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2000

Molecule: BI-671800
ChEMBL ID: CHEMBL551813
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL5479):

Molecule: RILOTUMUMAB
ChEMBL ID: CHEMBL1743063
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody

Molecule: FICLATUZUMAB
ChEMBL ID: CHEMBL1743018
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL5966):

Molecule: ROZANOLIXIZUMAB
ChEMBL ID: CHEMBL4297820
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2023

Molecule: EFGARTIGIMOD ALFA
ChEMBL ID: CHEMBL4297551
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 2021

Molecule: NIPOCALIMAB
ChEMBL ID: CHEMBL4594310
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Antibody

Molecule: BATOCLIMAB
ChEMBL ID: CHEMBL4650514
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody

Molecule: ORILANOLIMAB
ChEMBL ID: CHEMBL4298117
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Antibody
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2093867):

Molecule: GSK-690693
ChEMBL ID: CHEMBL494089
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: CEP-2563 DIHYDROCHLORIDE
ChEMBL ID: CHEMBL5314390
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: SOTRASTAURIN
ChEMBL ID: CHEMBL565612
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: UCN-01
ChEMBL ID: CHEMBL574737
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: MIDOSTAURIN
ChEMBL ID: CHEMBL608533
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2017
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2096907):

Molecule: ACADESINE
ChEMBL ID: CHEMBL1551724
Mechanism of Action: ACTIVATOR
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2111330):

Molecule: LY-2780301
ChEMBL ID: CHEMBL3545134
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: MSC-2363318A
ChEMBL ID: CHEMBL4871106
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: XL-418
ChEMBL ID: CHEMBL2016893
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: TAS0612
ChEMBL ID: CHEMBL4650277
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2221348):

Molecule: FLINDOKALNER
ChEMBL ID: CHEMBL266510
Mechanism of Action: ACTIVATOR
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2362984):

Molecule: PYRETHRINS
ChEMBL ID: CHEMBL2096637
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2000
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2362997):

Molecule: DECAMETHONIUM BROMIDE
ChEMBL ID: CHEMBL1134
Mechanism of Action: PARTIAL AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1982

Molecule: PANCURONIUM BROMIDE
ChEMBL ID: CHEMBL1200757
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1972

Molecule: CISATRACURIUM BESYLATE
ChEMBL ID: CHEMBL1200641
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1995

Molecule: GALLAMINE TRIETHIODIDE
ChEMBL ID: CHEMBL1200993
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1982

Molecule: DOXACURIUM CHLORIDE
ChEMBL ID: CHEMBL1237099
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1991

Molecule: RAPACURONIUM BROMIDE
ChEMBL ID: CHEMBL1200549
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1999

Molecule: PIPECURONIUM BROMIDE
ChEMBL ID: CHEMBL1200722
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1990

Molecule: ATRACURIUM BESYLATE
ChEMBL ID: CHEMBL1200527
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1983

Molecule: METOCURINE IODIDE
ChEMBL ID: CHEMBL1739
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1982

Molecule: MIVACURIUM CHLORIDE
ChEMBL ID: CHEMBL984
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1992

Molecule: ROCURONIUM BROMIDE
ChEMBL ID: CHEMBL1200648
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1994

Molecule: SUCCINYLCHOLINE CHLORIDE
ChEMBL ID: CHEMBL983
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1952

Molecule: TUBOCURARINE CHLORIDE
ChEMBL ID: CHEMBL3989821
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1945

Molecule: VECURONIUM BROMIDE
ChEMBL ID: CHEMBL1200629
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1984
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2363044):

Molecule: FOMEPIZOLE
ChEMBL ID: CHEMBL1308
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1997
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2363063):

Molecule: EZOGABINE
ChEMBL ID: CHEMBL41355
Mechanism of Action: OPENER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2011
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2363066):

Molecule: PENTOXIFYLLINE
ChEMBL ID: CHEMBL628
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1984

Molecule: DIPYRIDAMOLE
ChEMBL ID: CHEMBL932
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1961
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2363069):

Molecule: ADAPALENE
ChEMBL ID: CHEMBL1265
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1996

Molecule: TAZAROTENE
ChEMBL ID: CHEMBL1657
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1997

Molecule: TRETINOIN
ChEMBL ID: CHEMBL38
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1971

Molecule: ISOTRETINOIN
ChEMBL ID: CHEMBL547
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1982

Molecule: IRX4310
ChEMBL ID: CHEMBL3545173
Mechanism of Action: ANTAGONIST
Max Phase: 1.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2364153):

Molecule: USTEKINUMAB
ChEMBL ID: CHEMBL1201835
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2009

Molecule: BRIAKINUMAB
ChEMBL ID: CHEMBL1742995
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody

Molecule: EBDAROKIMAB
ChEMBL ID: CHEMBL4650437
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2364154):

Molecule: USTEKINUMAB
ChEMBL ID: CHEMBL1201835
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2009

Molecule: BRIAKINUMAB
ChEMBL ID: CHEMBL1742995
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody

Molecule: GUSELKUMAB
ChEMBL ID: CHEMBL2364648
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2017

Molecule: TILDRAKIZUMAB
ChEMBL ID: CHEMBL2108681
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2018

Molecule: BRAZIKUMAB
ChEMBL ID: CHEMBL3833372
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody

Molecule: RISANKIZUMAB
ChEMBL ID: CHEMBL3990029
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2019

Molecule: MIRIKIZUMAB
ChEMBL ID: CHEMBL3990014
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2023

Molecule: EBDAROKIMAB
ChEMBL ID: CHEMBL4650437
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2364167):

Molecule: ALDESLEUKIN
ChEMBL ID: CHEMBL1201438
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 1992

Molecule: DACLIZUMAB
ChEMBL ID: CHEMBL1201605
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 1997

Molecule: DENILEUKIN DIFTITOX
ChEMBL ID: CHEMBL1201550
Mechanism of Action: BINDING AGENT
Max Phase: 4.0
Molecule Type: Protein
First Approval: 1999

Molecule: BASILIXIMAB
ChEMBL ID: CHEMBL1201439
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 1998
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2364171):

Molecule: INTERFERON GAMMA-1B
ChEMBL ID: CHEMBL1201564
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 1999
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3559683):

Molecule: INDEGLITAZAR
ChEMBL ID: CHEMBL1232583
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: SODELGLITAZAR
ChEMBL ID: CHEMBL2104984
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: BEZAFIBRATE
ChEMBL ID: CHEMBL264374
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: LANIFIBRANOR
ChEMBL ID: CHEMBL4091374
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: CHIGLITAZAR
ChEMBL ID: CHEMBL4650349
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3580494):

Molecule: PEMTUMOMAB
ChEMBL ID: CHEMBL2109361
Mechanism of Action: BINDING AGENT
Max Phase: 3.0
Molecule Type: Antibody

Molecule: HUHMFG1
ChEMBL ID: CHEMBL2109637
Mechanism of Action: OTHER
Max Phase: 2.0
Molecule Type: Antibody

Molecule: SONTUZUMAB
ChEMBL ID: CHEMBL2108341
Mechanism of Action: OTHER
Max Phase: 2.0
Molecule Type: Antibody

Molecule: CANTUZUMAB MERTANSINE
ChEMBL ID: CHEMBL1742997
Mechanism of Action: BINDING AGENT
Max Phase: 2.0
Molecule Type: Antibody drug conjugate

Molecule: CANTUZUMAB RAVTANSINE
ChEMBL ID: CHEMBL1742998
Mechanism of Action: BINDING AGENT
Max Phase: 2.0
Molecule Type: Antibody drug conjugate

Molecule: AR-20.5
ChEMBL ID: CHEMBL2109364
Mechanism of Action: OTHER
Max Phase: 2.0
Molecule Type: Antibody

Molecule: SAR-566658
ChEMBL ID: CHEMBL2109635
Mechanism of Action: BINDING AGENT
Max Phase: 2.0
Molecule Type: Antibody drug conjugate

Molecule: HUPAM4
ChEMBL ID: CHEMBL2109365
Mechanism of Action: BINDING AGENT
Max Phase: 1.0
Molecule Type: Antibody

Molecule: EPITUMOMAB CITUXETAN
ChEMBL ID: CHEMBL2108592
Mechanism of Action: BINDING AGENT
Max Phase: 2.0
Molecule Type: Antibody drug conjugate

Molecule: EPITUMOMAB
ChEMBL ID: CHEMBL2108403
Mechanism of Action: BINDING AGENT
Max Phase: 2.0
Molecule Type: Antibody

Molecule: CMB-401
ChEMBL ID: CHEMBL2109284
Mechanism of Action: BINDING AGENT
Max Phase: 1.0
Molecule Type: Antibody

Molecule: AS-1403
ChEMBL ID: CHEMBL2109360
Mechanism of Action: BINDING AGENT
Max Phase: 1.0
Molecule Type: Antibody

Molecule: TECEMOTIDE
ChEMBL ID: CHEMBL3039544
Mechanism of Action: VACCINE ANTIGEN
Max Phase: 3.0
Molecule Type: Protein

Molecule: GATIPOTUZUMAB
ChEMBL ID: CHEMBL4297560
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3707192):

Molecule: FLINDOKALNER
ChEMBL ID: CHEMBL266510
Mechanism of Action: ACTIVATOR
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3831201):

Molecule: MARIZOMIB
ChEMBL ID: CHEMBL371405
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3831284):

Molecule: PEGINTERFERON LAMBDA-1A
ChEMBL ID: CHEMBL2108723
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Protein
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3832947):

Molecule: EPTINEZUMAB
ChEMBL ID: CHEMBL3833320
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2020

Molecule: GALCANEZUMAB
ChEMBL ID: CHEMBL3707328
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2018

Molecule: FREMANEZUMAB
ChEMBL ID: CHEMBL4297756
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2018
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL4622824):

Molecule: APRINOCARSEN
ChEMBL ID: CHEMBL2108287
Mechanism of Action: ANTISENSE INHIBITOR
Max Phase: 3.0
Molecule Type: Oligonucleotide

Molecule: APRINOCARSEN SODIUM
ChEMBL ID: CHEMBL2108985
Mechanism of Action: ANTISENSE INHIBITOR
Max Phase: -1.0
Molecule Type: Oligonucleotide
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL4630889):

Molecule: CODRITUZUMAB
ChEMBL ID: CHEMBL4298089
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL4804243):

Molecule: SIMUFILAM
ChEMBL ID: CHEMBL4650230
Mechanism of Action: POSITIVE MODULATOR
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL4804251):

Molecule: EFLEPEDOCOKIN ALFA
ChEMBL ID: CHEMBL4594542
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Protein
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL4804254):

Molecule: PEGILODECAKIN
ChEMBL ID: CHEMBL3989992
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Protein
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL5303569):

Molecule: IMEPITOIN
ChEMBL ID: CHEMBL204240
Mechanism of Action: PARTIAL AGONIST
Max Phase: -1.0
Molecule Type: Small molecule
First Approval: 2013
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL1892):

Molecule: MDX-070
ChEMBL ID: CHEMBL2109555
Mechanism of Action: OTHER
Max Phase: 2.0
Molecule Type: Antibody

Molecule: YTTRIUM Y 90 CAPROMAB PENDETIDE
ChEMBL ID: CHEMBL2109552
Mechanism of Action: BINDING AGENT
Max Phase: 2.0
Molecule Type: Antibody drug conjugate

Molecule: J591 177LU
ChEMBL ID: CHEMBL2109559
Mechanism of Action: BINDING AGENT
Max Phase: 2.0
Molecule Type: Antibody

Molecule: HUJ591 111IN
ChEMBL ID: CHEMBL2109677
Mechanism of Action: BINDING AGENT
Max Phase: 2.0
Molecule Type: Antibody

Molecule: MLN-2704
ChEMBL ID: CHEMBL2109556
Mechanism of Action: BINDING AGENT
Max Phase: 1.0
Molecule Type: Antibody drug conjugate

Molecule: HUJ591 177LU
ChEMBL ID: CHEMBL2109678
Mechanism of Action: BINDING AGENT
Max Phase: 2.0
Molecule Type: Antibody

Molecule: CYT-500 177LU
ChEMBL ID: CHEMBL2109553
Mechanism of Action: BINDING AGENT
Max Phase: 1.0
Molecule Type: Antibody

Molecule: LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN
ChEMBL ID: CHEMBL4594406
Mechanism of Action: BINDING AGENT
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2022
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2095165):

Molecule: GANETESPIB
ChEMBL ID: CHEMBL2103879
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: RETASPIMYCIN HYDROCHLORIDE
ChEMBL ID: CHEMBL377559
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: TANESPIMYCIN
ChEMBL ID: CHEMBL109480
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: CD24FC
ChEMBL ID: CHEMBL4297717
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Unknown

Molecule: BIIB021
ChEMBL ID: CHEMBL467399
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: ALVESPIMYCIN
ChEMBL ID: CHEMBL383824
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: ONALESPIB
ChEMBL ID: CHEMBL1214827
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: SNX 5422
ChEMBL ID: CHEMBL1195136
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: LUMINESPIB
ChEMBL ID: CHEMBL252164
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2363065):

Molecule: METFORMIN HYDROCHLORIDE
ChEMBL ID: CHEMBL1703
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1995

Molecule: ME-344
ChEMBL ID: CHEMBL5314386
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: NV-128
ChEMBL ID: CHEMBL3545135
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2364166):

Molecule: BEDAQUILINE FUMARATE
ChEMBL ID: CHEMBL2105700
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2012
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3286074):

Molecule: OLAPTESED PEGOL
ChEMBL ID: CHEMBL4594485
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Oligonucleotide
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3712988):

Molecule: IMC-GP100
ChEMBL ID: CHEMBL2109434
Mechanism of Action: CROSS-LINKING AGENT
Max Phase: -1.0
Molecule Type: Antibody

Molecule: TEBENTAFUSP
ChEMBL ID: CHEMBL4297990
Mechanism of Action: BINDING AGENT
Max Phase: 4.0
Molecule Type: Protein
First Approval: 2022
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3856162):

Molecule: IMGATUZUMAB
ChEMBL ID: CHEMBL2109389
Mechanism of Action: CROSS-LINKING AGENT
Max Phase: 2.0
Molecule Type: Antibody
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL4523585):

Molecule: GALIDESIVIR
ChEMBL ID: CHEMBL1236524
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL4630884):

Molecule: ANG1005
ChEMBL ID: CHEMBL1089636
Mechanism of Action: BINDING AGENT
Max Phase: 3.0
Molecule Type: Protein
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL4804253):

Molecule: IBOCTADEKIN
ChEMBL ID: CHEMBL2108034
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Protein
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2096668):

Molecule: NITREFAZOLE
ChEMBL ID: CHEMBL1909285
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2096904):

Molecule: DEXFENFLURAMINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1887891
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: ZIMELDINE HYDROCHLORIDE
ChEMBL ID: CHEMBL2355333
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: AMISULPRIDE
ChEMBL ID: CHEMBL243712
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1986
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2362996):

Molecule: DALFAMPRIDINE
ChEMBL ID: CHEMBL284348
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2010

Molecule: GUANIDINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1200728
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1939

Molecule: NERISPIRDINE
ChEMBL ID: CHEMBL2107762
Mechanism of Action: BLOCKER
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: TEDISAMIL
ChEMBL ID: CHEMBL2111110
Mechanism of Action: BLOCKER
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: AMIFAMPRIDINE
ChEMBL ID: CHEMBL354077
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2009

Molecule: AMIFAMPRIDINE PHOSPHATE
ChEMBL ID: CHEMBL3301611
Mechanism of Action: BLOCKER
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2009
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL2364701):

Molecule: CARFILZOMIB
ChEMBL ID: CHEMBL451887
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Protein
First Approval: 2009

Molecule: BORTEZOMIB
ChEMBL ID: CHEMBL325041
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2003

Molecule: IXAZOMIB CITRATE
ChEMBL ID: CHEMBL3545432
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2015

Molecule: OPROZOMIB
ChEMBL ID: CHEMBL2103884
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: IXAZOMIB
ChEMBL ID: CHEMBL2141296
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: BORTEZOMIB D-MANNITOL
ChEMBL ID: CHEMBL5315122
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2015
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL3831286):

Molecule: OMECAMTIV MECARBIL
ChEMBL ID: CHEMBL1800955
Mechanism of Action: ACTIVATOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: DANICAMTIV
ChEMBL ID: CHEMBL4594304
Mechanism of Action: ACTIVATOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: MAVACAMTEN
ChEMBL ID: CHEMBL4297517
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2022
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL4834389):

Molecule: COFIRASERSEN
ChEMBL ID: CHEMBL4650476
Mechanism of Action: ANTISENSE INHIBITOR
Max Phase: 2.0
Molecule Type: Oligonucleotide
Drug and clinical candidate information for tumor_necrosis_factor-alpha (ChEMBL ID: CHEMBL5303570):

Molecule: TIGILANOL TIGLATE
ChEMBL ID: CHEMBL3989916
Mechanism of Action: ACTIVATOR
Max Phase: 2.0
Molecule Type: Small molecule
First Approval: 2020
